Gianfranco Sinagra

Gianfranco Sinagra's AcademicInfluence.com Rankings

Gianfranco Sinagra

Computer Science

#3851

World Rank

#4047

Historical Rank

Machine Learning

#579

World Rank

#586

Historical Rank

Artificial Intelligence

#782

World Rank

#794

Historical Rank

Database

#1106

World Rank

#1163

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Gianfranco Sinagra's Degrees

PhD Computer Science University of Milan
Bachelors Computer Science University of Milan

Similar Degrees You Can Earn

Why Is Gianfranco Sinagra Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Gianfranco Sinagra's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). (2020) (1587)
[ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: what's new?] (2022) (1392)
Truncations of titin causing dilated cardiomyopathy. (2012) (1082)
Functional screening identifies miRNAs inducing cardiac regeneration (2012) (923)
Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era (2020) (673)
Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era (2020) (673)
Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction. (2003) (529)
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial (2017) (464)
Natural history of dilated cardiomyopathy due to lamin A/C gene mutations. (2003) (414)
Restrictive left ventricular filling pattern in dilated cardiomyopathy assessed by Doppler echocardiography: clinical, echocardiographic and hemodynamic correlations and prognostic implications. Heart Muscle Disease Study Group. (1993) (347)
Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement. (2000) (336)
Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases. (2013) (316)
Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment. (2011) (305)
Vascular endothelial growth factor stimulates skeletal muscle regeneration in vivo. (2004) (297)
Genetic Variation in Titin in Arrhythmogenic Right Ventricular Cardiomyopathy–Overlap Syndromes (2011) (286)
The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review (2001) (271)
MicroRNA therapy stimulates uncontrolled cardiac repair after myocardial infarction in pigs (2019) (270)
Genetic association study of QT interval highlights role for calcium signaling pathways in myocardial repolarization (2014) (260)
Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology (EAPC). (2018) (250)
Persistence of restrictive left ventricular filling pattern in dilated cardiomyopathy: an ominous prognostic sign. (1997) (241)
Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry. (2015) (235)
α-Myosin Heavy Chain: A Sarcomeric Gene Associated With Dilated and Hypertrophic Phenotypes of Cardiomyopathy (2005) (223)
Clinical StudiesFamilial dilated cardiomyopathy: Evidence for genetic and phenotypic heterogeneity☆ (1999) (217)
Evolving concepts in dilated cardiomyopathy (2018) (205)
SCN5A mutations associate with arrhythmic dilated cardiomyopathy and commonly localize to the voltage-sensing mechanism. (2011) (204)
Thymopoietin (lamina‐associated polypeptide 2) gene mutation associated with dilated cardiomyopathy (2005) (191)
A new locus for arrhythmogenic right ventricular dysplasia on the long arm of chromosome 14. (1996) (186)
Prevalence of Desmin Mutations in Dilated Cardiomyopathy (2007) (180)
Left ventricular involvement in right ventricular dysplasia. (1992) (177)
Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity. Heart Muscle Disease Study Group. (1999) (169)
Cardiomyocyte VEGFR‐1 activation by VEGF‐B induces compensatory hypertrophy and preserves cardiac function after myocardial infarction (2010) (164)
Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: a multiparametric approach to heart failure prognosis. (2013) (164)
Long‐term prognostic impact of therapeutic strategies in patients with idiopathic dilated cardiomyopathy: changing mortality over the last 30 years (2014) (158)
Notch1 signaling stimulates proliferation of immature cardiomyocytes (2008) (155)
Linkage of familial dilated cardiomyopathy to chromosome 9. Heart Muscle Disease Study Group. (1995) (147)
Multilevel analyses of SCN5A mutations in arrhythmogenic right ventricular dysplasia/cardiomyopathy suggest non-canonical mechanisms for disease pathogenesis (2017) (140)
Long-Term Evolution and Prognostic Stratification of Biopsy-Proven Active Myocarditis (2013) (136)
Single-Dose Intracardiac Injection of Pro-Regenerative MicroRNAs Improves Cardiac Function After Myocardial Infarction (2017) (135)
Induction of functional neovascularization by combined VEGF and angiopoietin-1 gene transfer using AAV vectors. (2003) (132)
Pulmonary hypertension and pregnancy outcomes: data from the Registry Of Pregnancy and Cardiac Disease (ROPAC) of the European Society of Cardiology (2016) (131)
Prognostic predictors in arrhythmogenic right ventricular cardiomyopathy: results from a 10-year registry. (2011) (125)
Myocarditis in Clinical Practice. (2016) (124)
Filamin C Truncation Mutations Are Associated With Arrhythmogenic Dilated Cardiomyopathy and Changes in the Cell–Cell Adhesion Structures (2018) (123)
Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol (1999) (123)
Genetic Risk of Arrhythmic Phenotypes in Patients With Dilated Cardiomyopathy. (2019) (123)
Acute heart failure congestion and perfusion status – impact of the clinical classification on in‐hospital and long‐term outcomes; insights from the ESC‐EORP‐HFA Heart Failure Long‐Term Registry (2019) (121)
Association of Troponin Levels With Mortality in Italian Patients Hospitalized With Coronavirus Disease 2019: Results of a Multicenter Study. (2020) (121)
Paracrine effect of regulatory T cells promotes cardiomyocyte proliferation during pregnancy and after myocardial infarction (2018) (114)
Fulminant Versus Acute Nonfulminant Myocarditis in Patients With Left Ventricular Systolic Dysfunction. (2019) (109)
Increased expression and secretion of resistin in epicardial adipose tissue of patients with acute coronary syndrome. (2010) (104)
Prevalence and prognostic impact of non‐cardiac co‐morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community‐based study (2018) (104)
Arrhythmogenic Phenotype in Dilated Cardiomyopathy: Natural History and Predictors of Life‐Threatening Arrhythmias (2015) (102)
52 Genetic Loci Influencing Myocardial Mass. (2016) (98)
Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID‐19. Results of the Cardio‐COVID‐Italy multicentre study (2020) (95)
[Prevention of heart failure]. (2010) (92)
Epidemiology of dilated cardiomyopathy. A prospective post-mortem study of 5252 necropsies. The Heart Muscle Disease Study Group. (1997) (91)
The Cardiomyopathy Registry of the EURObservational Research Programme of the European Society of Cardiology: baseline data and contemporary management of adult patients with cardiomyopathies (2018) (88)
Bone marrow cells recruited through the neuropilin-1 receptor promote arterial formation at the sites of adult neoangiogenesis in mice. (2008) (88)
Electrocardiographic Criteria of True Left Bundle Branch Block: A Simple Sign to Predict a Better Clinical and Instrumental Response to CRT (2012) (87)
Inflammasome formation in the lungs of patients with fatal COVID-19 (2020) (87)
Dystrophin gene abnormalities in two patients with idiopathic dilated cardiomyopathy (1997) (84)
Clinical Spectrum of PRKAG2 Syndrome (2016) (82)
Cardiopulmonary responses and prognosis in hypertrophic cardiomyopathy: a potential role for comprehensive noninvasive hemodynamic assessment. (2015) (82)
FLNC Gene Splice Mutations Cause Dilated Cardiomyopathy (2016) (82)
Improved exercise hemodynamic status in dilated cardiomyopathy after beta-adrenergic blockade treatment. (1994) (79)
Efficacy of Ranolazine in Patients With Symptomatic Hypertrophic Cardiomyopathy: The RESTYLE-HCM Randomized, Double-Blind, Placebo-Controlled Study (2018) (78)
A Review of the Giant Protein Titin in Clinical Molecular Diagnostics of Cardiomyopathies (2016) (77)
Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy (2018) (77)
GENETIC CAUSES OF DILATED CARDIOMYOPATHY. (2014) (77)
Sex-Based Differences in Heart Failure Across the Ejection Fraction Spectrum: Phenotyping, and Prognostic and Therapeutic Implications. (2019) (76)
Treatment of chronic heart failure with β adrenergic blockade beyond controlled clinical trials: the BRING-UP experience (2003) (76)
The Prognostic Impact of the Evolution of RV Function in Idiopathic DCM. (2016) (75)
Persistent Recovery of Normal Left Ventricular Function and Dimension in Idiopathic Dilated Cardiomyopathy During Long‐Term Follow‐up: Does Real Healing Exist? (2015) (75)
Right Ventricular Strain and Dyssynchrony Assessment in Arrhythmogenic Right Ventricular Cardiomyopathy: Cardiac Magnetic Resonance Feature-Tracking Study (2015) (75)
Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: a long‐term comparison (2017) (74)
Utility of cardiac magnetic resonance imaging to differentiate cardiac sarcoidosis from arrhythmogenic right ventricular cardiomyopathy. (2012) (74)
Heart failure with mid-range or mildly reduced ejection fraction (2021) (74)
Permanent atrial fibrillation affects exercise capacity in chronic heart failure patients. (2008) (71)
Changing mortality in dilated cardiomyopathy (1994) (70)
Infarct-related artery occlusion, tissue markers of ischaemia, and increased apoptosis in the peri-infarct viable myocardium. (2005) (69)
Prognostic impact of familial screening in dilated cardiomyopathy (2010) (68)
Role of Titin Missense Variants in Dilated Cardiomyopathy (2015) (68)
The K219T-Lamin mutation induces conduction defects through epigenetic inhibition of SCN5A in human cardiac laminopathy (2019) (66)
Exercise tolerance can explain the obesity paradox in patients with systolic heart failure: data from the MECKI Score Research Group (2016) (65)
Formation of the inflammasome in acute myocarditis. (2014) (62)
PR interval genome-wide association meta-analysis identifies 50 loci associated with atrial and atrioventricular electrical activity (2018) (61)
Long-term evolution of right ventricular dysplasia-cardiomyopathy (1995) (59)
Impact of ambulatory cardiac rehabilitation on cardiovascular outcomes: a long-term follow-up study (2018) (59)
Prognostic Value of Indeterminable Anaerobic Threshold in Heart Failure (2013) (58)
A meta-analysis of genome-wide association studies of the electrocardiographic early repolarization pattern. (2012) (58)
Prognostic Value of Magnetic Resonance Phenotype in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy. (2020) (58)
Association between mutation status and left ventricular reverse remodelling in dilated cardiomyopathy (2017) (57)
International Prospective Registry of Acute Coronary Syndromes in Patients With COVID-19 (2021) (57)
Prevalence and clinical correlates of right ventricular dysfunction in patients with hypertrophic cardiomyopathy. (2013) (56)
How can optimization of medical treatment avoid unnecessary implantable cardioverter-defibrillator implantations in patients with idiopathic dilated cardiomyopathy presenting with "SCD-HeFT criteria?". (2012) (55)
Gene Therapy for the Heart Lessons Learned and Future Perspectives (2020) (54)
Poor Prognosis of Rare Sarcomeric Gene Variants in Patients with Dilated Cardiomyopathy (2013) (53)
The Italian Registry for hypertrophic cardiomyopathy: a nationwide survey. (2005) (52)
Inflammation impairs eNOS activation by HDL in patients with acute coronary syndrome. (2013) (51)
Natural History of Dilated Cardiomyopathy in Children (2016) (51)
Reverse remodeling in Dilated Cardiomyopathy: Insights and future perspectives (2018) (50)
Early improvement of functional mitral regurgitation in patients with idiopathic dilated cardiomyopathy. (2015) (49)
Cardiac Tumors: Diagnosis, Prognosis, and Treatment (2020) (49)
Dobutamine echocardiography in idiopathic dilated cardiomyopathy: clinical and prognostic implications (2002) (47)
Prognostic Impact of Diabetes and Prediabetes on Survival Outcomes in Patients With Chronic Heart Failure: A Post‐Hoc Analysis of the GISSI‐HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca‐Heart Failure) Trial (2017) (47)
Prognostic Impact of Diabetes and Prediabetes on Survival Outcomes in Patients With Chronic Heart Failure: A Post‐Hoc Analysis of the GISSI‐HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca‐Heart Failure) Trial (2017) (47)
A ZASP Missense Mutation, S196L, Leads to Cytoskeletal and Electrical Abnormalities in a Mouse Model of Cardiomyopathy (2010) (46)
A predictive scoring system for deep sternal wound infection after bilateral internal thoracic artery grafting. (2016) (46)
New-onset left bundle branch block independently predicts long-term mortality in patients with idiopathic dilated cardiomyopathy: data from the Trieste Heart Muscle Disease Registry. (2014) (46)
Long-term outcome of 'super-responder' patients to cardiac resynchronization therapy. (2014) (46)
Heart failure prognosis over time: how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years (2019) (45)
Toward standardization of echocardiography for the evaluation of left ventricular function in adult rodents: a position paper of the ESC Working Group on Myocardial Function. (2020) (45)
Cardiovascular mortality and chronotropic incompetence in systolic heart failure: the importance of a reappraisal of current cut‐off criteria (2014) (44)
Usefulness of high-dose intravenous human immunoglobulins treatment for refractory recurrent pericarditis. (2013) (44)
Takotsubo is not a cardiomyopathy. (2017) (44)
Malfunction of cardiac devices after radiotherapy without direct exposure to ionizing radiation: mechanisms and experimental data. (2016) (43)
Natural history of dilated cardiomyopathy: from asymptomatic left ventricular dysfunction to heart failure – a subgroup analysis from the Trieste Cardiomyopathy Registry (2009) (42)
Fatal myocarditis: morphologic and clinical features. (2004) (42)
Self-reported physical activity and major adverse events in patients with atrial fibrillation: a report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry (2016) (42)
Relation between the plasma levels of LDL-cholesterol and the expression of the early marker of inflammation long pentraxin PTX3 and the stress response gene p66(ShcA) in pacemaker-implanted patients (2007) (42)
Are Nonsustained Ventricular Tachycardias Predictive of Major Arrhythmias in Patients with Dilated Cardiomyopathy on Optimal Medical Treatment? (2008) (42)
Quantitative angiography and optical coherence tomography for the functional assessment of nonobstructive coronary stenoses: comparison with fractional flow reserve. (2013) (41)
Cardiac Biomarkers in the Emergency Department: The Role of Soluble ST2 (sST2) in Acute Heart Failure and Acute Coronary Syndrome—There is Meat on the Bone (2019) (40)
Epidemiology of dilated cardiomyopathy (1997) (40)
Percutaneous mitral valve repair: The last chance for symptoms improvement in advanced refractory chronic heart failure? (2017) (40)
The Electrocardiogram in the Diagnosis and Management of Patients with Hypertrophic Cardiomyopathy. (2019) (40)
Predicting atrial fibrillation recurrence with circulating inflammatory markers in patients in sinus rhythm at high risk for atrial fibrillation: data from the GISSI atrial fibrillation trial (2010) (40)
Vitamin D Deficiency in Patients with Acute Myocardial Infarction: An Italian Single-Center Study. (2015) (40)
Titin and desmosomal genes in the natural history of arrhythmogenic right ventricular cardiomyopathy (2014) (39)
The electrocardiogram in the diagnosis and management of patients with dilated cardiomyopathy (2020) (38)
Contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention without acute left ventricular ejection fraction impairment. (2013) (38)
Multi-ancestry GWAS of the electrocardiographic PR interval identifies 202 loci underlying cardiac conduction (2019) (38)
Arrhythmogenic right ventricular cardiomyopathy: From genetics to diagnostic and therapeutic challenges. (2014) (37)
MiR-320a as a Potential Novel Circulating Biomarker of Arrhythmogenic CardioMyopathy (2017) (37)
Contemporary survival trends and aetiological characterization in non‐ischaemic dilated cardiomyopathy (2020) (37)
Clinical Phenotypes and Prognosis of Dilated Cardiomyopathy Caused by Truncating Variants in the TTN Gene (2020) (37)
Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review (2021) (37)
Simple Scoring System to Predict In‐Hospital Mortality After Surgery for Infective Endocarditis (2017) (37)
Acylated ghrelin treatment normalizes skeletal muscle mitochondrial oxidative capacity and AKT phosphorylation in rat chronic heart failure (2017) (37)
Adverse outcomes in patients with atrial fibrillation and peripheral arterial disease: a report from the EURObservational research programme pilot survey on atrial fibrillation (2017) (37)
Exome-chip meta-analysis identifies novel loci associated with cardiac conduction, including ADAMTS6 (2018) (37)
Phenotypic clustering of dilated cardiomyopathy patients highlights important pathophysiological differences (2020) (37)
COVID‐19 and renin‐angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) ‐ Is there any scientific evidence for controversy? (2020) (37)
Sex Differences in the Long-term Prognosis of Dilated Cardiomyopathy. (2019) (36)
Echocardiographic evaluation of systolic and mean pulmonary artery pressure in the follow-up of patients with pulmonary hypertension. (2011) (36)
Right ventricular dysplasia: a clinical and pathological study of two families with left ventricular involvement. (1993) (36)
Right ventricular cardiomyocyte apoptosis in patients with acute myocardial infarction of the left ventricular wall. (2008) (36)
Beta blockers in patients with congestive heart failure: guided use in clinical practice Investigators. Treatment of chronic heart failure with beta adrenergic blockade beyond controlled clinical trials: the BRING-UP experience (2003) (35)
Patients with chronic heart failure encountered in daily clinical practice are different from the "typical" patient enrolled in therapeutic trials. (2003) (35)
Sudden coronary death, fatal acute myocardial infarction and widespread coronary and myocardial inflammation (2007) (34)
Prognostic Value of Late Gadolinium Enhancement for the Prediction of Cardiovascular Outcomes in Dilated Cardiomyopathy (2020) (33)
Multi-state modelling of heart failure care path: A population-based investigation from Italy (2017) (32)
Apoptosis in patients with acute myocarditis. (2009) (32)
Whole Exome Sequencing Identifies a Troponin T Mutation Hot Spot in Familial Dilated Cardiomyopathy (2013) (32)
Predictors for restoration of normal left ventricular function in response to cardiac resynchronization therapy measured at time of implantation. (2011) (31)
Overview and Comparison of Infectious Endocarditis and Non-infectious Endocarditis: A Review of 814 Autoptic Cases (2019) (31)
Clinical presentation and long-term follow-up of perimyocarditis (2013) (31)
Potential risk of beta-blockade withdrawal in congestive heart failure due to abrupt autonomic changes. (1999) (31)
Impact of Demographic Features, Lifestyle, and Comorbidities on the Clinical Expression of Hypertrophic Cardiomyopathy (2017) (31)
Ankyrin-B dysfunction predisposes to arrhythmogenic cardiomyopathy and is amenable to therapy. (2019) (30)
Early Arrhythmic Events in Idiopathic Dilated Cardiomyopathy. (2016) (30)
Reference Values for Peak Exercise Cardiac Output in Healthy Individuals (2017) (30)
n‐3 polyunsaturated fatty acids and atrial fibrillation in patients with chronic heart failure: the GISSI‐HF trial (2013) (29)
Changing mortality in dilated cardiomyopathy. The Heart Muscle Disease Study Group. (1994) (29)
Long-term outcome of nonobstructive versus obstructive hypertrophic cardiomyopathy: A systematic review and meta-analysis. (2017) (29)
Heart failure and anemia: Effects on prognostic variables. (2017) (29)
The metabolic exercise test data combined with Cardiac And Kidney Indexes (MECKI) score and prognosis in heart failure. A validation study. (2016) (29)
Deceptive meaning of oxygen uptake measured at the anaerobic threshold in patients with systolic heart failure and atrial fibrillation (2015) (28)
FLNC truncations cause arrhythmogenic right ventricular cardiomyopathy (2020) (28)
Insights into mildly dilated cardiomyopathy: temporal evolution and long‐term prognosis (2017) (28)
Genetics of Dilated Cardiomyopathy: Clinical Implications (2018) (28)
Routine use of bilateral internal thoracic artery grafts for left-sided myocardial revascularization in insulin-dependent diabetic patients: early and long-term outcomes. (2015) (28)
Impact of Atrial Fibrillation on Outcome of Patients with Idiopathic Dilated Cardiomyopathy: Data from the Heart Muscle Disease Registry of Trieste (2010) (28)
Gender-related differences in heart failure: beyond the “one-size-fits-all” paradigm (2019) (27)
Pathways for salvage and protection of the heart under stress: novel routes for cardiac rejuvenation. (2016) (27)
Cardiac and Neuromuscular Features of Patients With LMNA-Related Cardiomyopathy (2019) (27)
Familial right ventricular dysplasia with biventricular involvement and inflammatory infiltration. Heart Muscle Disease Study Group. (1996) (27)
Bilateral internal thoracic artery grafting in octogenarians: where are the benefits? (2016) (27)
Electrocardiographic differentiation between ‘benign T-wave inversion’ and arrhythmogenic right ventricular cardiomyopathy (2018) (27)
Autophagy and Inflammasome Activation in Dilated Cardiomyopathy (2019) (27)
Renal function and peak exercise oxygen consumption in chronic heart failure with reduced left ventricular ejection fraction. (2015) (27)
Transthyretin amyloid cardiomyopathy: An uncharted territory awaiting discovery (2020) (27)
The Role of NLRP3 Inflammasome in Pericarditis (2021) (27)
Current perspective new insights into the molecular basis of familial dilated cardiomyopathy. (2001) (27)
ACEF and clinical SYNTAX score in the risk stratification of patients with heavily calcified coronary stenosis undergoing rotational atherectomy with stent implantation (2014) (27)
Prognostic Role of Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Low-to-Intermediate Sudden Cardiac Death Risk Score. (2019) (27)
Is high pressure postdilation safe in bioresorbable vascular scaffolds? Optical coherence tomography observations after noncompliant balloons inflated at more than 24 atmospheres (2015) (26)
Prognostic value of cardiopulmonary exercise testing in Idiopathic Dilated Cardiomyopathy. (2016) (26)
Genome-wide association meta-analysis of 30,000 samples identifies seven novel loci for quantitative ECG traits (2019) (26)
Prognostic role of β‐blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database (2017) (26)
Risk Stratification in Arrhythmic Right Ventricular Cardiomyopathy Without Implantable Cardioverter-Defibrillators. (2016) (26)
Short-term mechanical unloading and reverse remodeling of failing hearts in children. (2010) (26)
Pulmonary embolism in patients with COVID-19: characteristics and outcomes in the Cardio-COVID Italy multicenter study (2020) (25)
Pharmacological therapy for the prevention of cardiovascular events in patients with myocardial infarction with non-obstructed coronary arteries (MINOCA): Insights from a multicentre national registry. (2020) (25)
Predicting device failure after percutaneous repair of functional mitral regurgitation in advanced heart failure: Implications for patient selection. (2018) (25)
Arrhythmic Risk Stratification in Patients With Idiopathic Dilated Cardiomyopathy. (2018) (24)
Severe heart failure prognosis evaluation for transplant selection in the era of beta-blockers: role of peak oxygen consumption. (2013) (24)
Flexible band versus rigid ring annuloplasty for functional tricuspid regurgitation: two different patterns of right heart reverse remodelling. (2016) (23)
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC‐TIVE study, an Italian nationwide survey (2022) (23)
Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study (2021) (23)
Obesity and high waist circumference are associated with low circulating pentraxin-3 in acute coronary syndrome (2013) (23)
Cardiac hypertrophy, accessory pathway, and conduction system disease in an adolescent: the PRKAG2 cardiac syndrome. (2013) (23)
Predictive role of CHA2DS2-VASc score for cardiovascular events and death in patients with arterial hypertension and stable sinus rhythm (2017) (23)
Association between beta‐blocker use and mortality/morbidity in older patients with heart failure with reduced ejection fraction. A propensity score‐matched analysis from the Swedish Heart Failure Registry (2019) (23)
The progression of left ventricular systolic and diastolic dysfunctions in hypertrophic cardiomyopathy: clinical and prognostic significance (2010) (23)
Prevalence and prognostic role of right ventricular involvement in stress-induced cardiomyopathy. (2015) (22)
Idiopathic left ventricular aneurysm: a clinical and pathological study of a new entity in the spectrum of cardiomyopathies. (1994) (22)
A risk factor analysis for in-hospital mortality after surgery for infective endocarditis and a proposal of a new predictive scoring system (2017) (22)
Left ventricular involvement in right ventricular cardiomyopathy. (1989) (22)
Sacubitril/Valsartan Induces Global Cardiac Reverse Remodeling in Long-Lasting Heart Failure with Reduced Ejection Fraction: Standard and Advanced Echocardiographic Evidences (2020) (22)
Metoprolol in dilated cardiomyopathy: Is it possible toidentify factors predictive of improvement? (1996) (22)
Idiopathic dilated cardiomyopathy and persistent viral infection: lack of association in a controlled study using a quantitative assay. (2012) (22)
Role of right ventricular involvement in acute myocarditis, assessed by cardiac magnetic resonance. (2018) (22)
Elevations of inflammatory markers PTX3 and sST2 after resuscitation from cardiac arrest are associated with multiple organ dysfunction syndrome and early death (2015) (21)
Myocarditis evolving in cardiomyopathy: when genetics and offending causes work together (2019) (21)
Mild inflammatory activation of mammary arteries in patients with acute coronary syndromes. (2008) (21)
Prognostic significance of atrial fibrillation and severity of symptoms of heart failure in patients with low gradient aortic stenosis and preserved left ventricular ejection fraction. (2014) (21)
Impact of Septal Reduction on Left Atrial Size and Diastole in Hypertrophic Cardiomyopathy (2016) (21)
The prognostic value of serial troponin measurements in patients admitted for COVID‐19 (2021) (21)
Critical Comparison of Documents From Scientific Societies on Cardiac Amyloidosis: JACC State-of-the-Art Review. (2022) (21)
Prognostic Role of Cardiac Magnetic Resonance in Arrhythmogenic Right Ventricular Cardiomyopathy. (2018) (20)
Potent inhibition of arterial intimal hyperplasia by TIMP1 gene transfer using AAV vectors. (2004) (20)
Interleukin-1β levels predict long-term mortality and need for heart transplantation in ambulatory patients affected by idiopathic dilated cardiomyopathy (2017) (20)
[Isolated left ventricular non-compaction]. (2005) (19)
Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol. The Heart-Muscle Disease Study Group. (1999) (19)
Intracellular Function of Interleukin-1 Receptor Antagonist in Ischemic Cardiomyocytes (2013) (19)
Prognostic Impact of BNP Variations in Patients Admitted for Acute Decompensated Heart Failure with In-Hospital Worsening Renal Function. (2017) (19)
Heart failure in COVID‐19: the multicentre, multinational PCHF‐COVICAV registry (2021) (19)
Clinical management of dilated cardiomyopathy: current knowledge and future perspectives (2016) (19)
High-throughput Genotyping Robot-assisted Method for Mutation Detection in Patients With Hypertrophic Cardiomyopathy (2011) (19)
Tricuspid Annuloplasty for Tricuspid Regurgitation Secondary to Left-Sided Heart Valve Disease: Immediate Outcomes and Risk Factors for Late Failure. (2016) (19)
Incremental prognostic value of restrictive filling pattern in hypertrophic cardiomyopathy: a Doppler echocardiographic study. (2006) (19)
Atrial fibrillation in dilated cardiomyopathy: Outcome prediction from an observational registry. (2020) (18)
Arrhythmic risk stratification in non-ischaemic dilated cardiomyopathy beyond ejection fraction (2020) (18)
Polypoid osteosarcoma of the left atrium: report of a new case with autopsy confirmation and review of the literature. (1998) (18)
Impaired Right Ventricular Longitudinal Strain Without Pulmonary Hypertension in Patients Who Have Recovered From COVID-19. (2021) (18)
Sex Profile and Risk Assessment With Cardiopulmonary Exercise Testing in Heart Failure: Propensity Score Matching for Sex Selection Bias. (2016) (18)
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction (2020) (18)
Dilated cardiomyopathy: so many cardiomyopathies! (2019) (18)
Acute Hemodynamic Response to Cardiac Resynchronization in Dilated Cardiomyopathy: Effect on Late Mitral Regurgitation (2015) (18)
Incidence and Characterization of Concealed Cardiac Amyloidosis Among Unselected Elderly Patients Undergoing Post-mortem Examination (2021) (18)
ECG in dilated cardiomyopathy: specific findings and long-term prognostic significance. (2019) (18)
Use of sodium–glucose co‐transporter 2 inhibitors in patients with heart failure and type 2 diabetes mellitus: data from the Swedish Heart Failure Registry (2021) (17)
Left bundle branch block-induced cardiomyopathy: a diagnostic proposal for a poorly explored pathological entity. (2020) (17)
Clinical relevance of right ventricular dysplasia/cardiomyopathy (2000) (17)
Diagnosis and management of rare cardiomyopathies in adult and paediatric patients. (2022) (17)
Post‐discharge arrhythmic risk stratification of patients with acute myocarditis and life‐threatening ventricular tachyarrhythmias (2021) (17)
Dilated Cardiomyopathy : From Genetics to Clinical Management (2019) (17)
Incidence and risk factors for pacemaker implantation in light‐chain and transthyretin cardiac amyloidosis (2022) (16)
Efficacy of high-dose intravenous immunoglobulins in two patients with idiopathic recurrent pericarditis refractory to previous immunosuppressive treatment. (2003) (16)
The peculiar role of vitamin D in the pathophysiology of cardiovascular and neurodegenerative diseases. (2021) (16)
Viral presence‐guided immunomodulation in lymphocytic myocarditis: an update (2020) (16)
Prognostic role of non-sustained ventricular tachycardia in a large cohort of patients with idiopathic dilated cardiomyopathy. (2005) (16)
Use of evidence‐based therapy in heart failure with reduced ejection fraction across age strata (2022) (16)
Increased serum uric acid level predicts poor prognosis in mildly severe chronic heart failure with reduced ejection fraction. An analysis from the MECKI score research group. (2019) (16)
Infective endocarditis in elderly: an Italian prospective multi-center observational study. (2014) (16)
Lymphocytic Myocarditis: A Genetically Predisposed Disease? (2020) (16)
Incidence and predictors of sudden cardiac death during long-term follow-up in patients with dilated cardiomyopathy on optimal medical therapy. (2001) (16)
Seventeen-year trend (2001-2017) in pacemaker and implantable cardioverter-defibrillator utilization based on hospital discharge database data: An analysis by age groups. (2020) (16)
[The natural history of dilated cardiomyopathy: a review of the Heart Muscle Disease Registry of Trieste]. (2004) (16)
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization-the first insight from the AC-TIVE Study. (2021) (16)
Prognostic role of atrial fibrillation in patients affected by chronic heart failure. Data from the MECKI score research group. (2015) (16)
ST-elevation myocardial infarction with reduced left ventricular ejection fraction: Insights into persisting left ventricular dysfunction. A pPCI-registry analysis. (2016) (16)
Clinical and prognostic impact of chronotropic incompetence in patients with hypertrophic cardiomyopathy. (2018) (16)
Comparison of Patient Characteristics and Course of Hypertensive Hypokinetic Cardiomyopathy Versus Idiopathic Dilated Cardiomyopathy. (2017) (16)
Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta‐analysis of screening studies (2022) (16)
Critical role of lysosomes in the dysfunction of human Cardiac Stem Cells obtained from failing hearts. (2016) (16)
Latent obstruction and left atrial size are predictors of clinical deterioration leading to septal reduction in hypertrophic cardiomyopathy. (2014) (15)
Early right ventricular response to cardiac resynchronization therapy: impact on clinical outcomes (2016) (15)
The plasma concentration of Lpa-I:A-II particles as a predictor of the inflammatory response in patients with ST-elevation myocardial infarction. (2009) (15)
Implantable cardioverter-defibrillator-computed respiratory disturbance index accurately identifies severe sleep apnea: The DASAP-HF study. (2017) (15)
Viral genome search in myocardium of patients with fulminant myocarditis (2020) (15)
How does morphology impact on diastolic function in hypertrophic cardiomyopathy? A single centre experience (2014) (15)
Long term survival effect of metoprolol in dilated cardiomyopathy (1998) (15)
Focus on cardiac amyloidosis: a single-center experience with a long-term follow-up (2013) (15)
Current diagnostic strategies for dilated cardiomyopathy: a comparison of imaging techniques (2018) (15)
U-shaped relationship between vitamin D levels and long-term outcome in large cohort of survivors of acute myocardial infarction. (2016) (15)
Strain analysis reveals subtle systolic dysfunction in confirmed and suspected myocarditis with normal LVEF. A cardiac magnetic resonance study (2019) (15)
Anaerobic Threshold and Respiratory Compensation Point Identification During Cardiopulmonary Exercise Tests in Chronic Heart Failure. (2019) (15)
Clinical importance of late gadolinium enhancement at right ventricular insertion points in otherwise normal hearts (2020) (15)
Lifelong arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy: distribution of events and impact of periodical reassessment. (2018) (14)
Adipokines, Ghrelin and Obesity‐Associated Insulin Resistance in Nondiabetic Patients with Acute Coronary Syndrome (2012) (14)
Phenotypic Expression, Natural History and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating Variants. (2021) (14)
The syndrome of right bundle branch block, persistent ST segment elevation and sudden cardiac death. Which is the histological substrate? (1997) (14)
Role of circulating factors in cardiac aging. (2017) (14)
Exercise oscillatory ventilation and prognosis in heart failure patients with reduced and mid‐range ejection fraction (2019) (14)
Metoprolol in dilated cardiomyopathy: is it possible to identify factors predictive of improvement? The Heart Muscle Disease Study Group. (1996) (14)
Rationale for cardiopulmonary exercise test in the assessment of surgical risk (2013) (14)
Cardiac amyloidosis: do not forget to look for it (2020) (14)
Comparison of different prediction models for the indication of implanted cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy (2020) (14)
Persistent left ventricular dysfunction after acute lymphocytic myocarditis: Frequency and predictors (2019) (14)
Arrhythmic risk prediction of acute myocarditis presenting with life-threatening ventricular tachyarrhythmias. (2016) (13)
Prognostic role of clinical presentation in symptomatic patients with hypertrophic cardiomyopathy (2012) (13)
Myocardial iron overload by cardiovascular magnetic resonance native segmental T1 mapping: a sensitive approach that correlates with cardiac complications (2021) (13)
Synergistic effect of thrombus aspiration and abciximab in primary percutaneous coronary intervention (2013) (13)
Predictors of immediate and long-term outcomes of coronary bypass surgery in patients with left ventricular dysfunction (2016) (13)
Accuracy of right atrial pressure estimation using a multi-parameter approach derived from inferior vena cava semi-automated edge-tracking echocardiography: a pilot study in patients with cardiovascular disorders (2020) (13)
SARS-CoV-2, myocardial injury and inflammation: insights from a large clinical and autopsy study (2021) (13)
Short and long-term outcome in very old patients with ST-elevation myocardial infarction after primary percutaneous coronary intervention. (2017) (13)
Left ventricular noncompaction, morphological, and clinical features for an integrated diagnosis (2019) (13)
Chronic thromboembolic pulmonary hypertension (CTEPH): what do we know about it? A comprehensive review of the literature (2019) (13)
Endomyocardial biopsy in dilated cardiomyopathy and myocarditis: which role? (1991) (13)
Prognostic significance of unexplained left ventricular hypertrophy in patients undergoing carpal tunnel surgery (2021) (13)
Reliability of noninvasive hemodynamic assessment with Doppler echocardiography: comparison with the invasive evaluation. (2019) (12)
Heart failure impairs the mechanotransduction propeties of human cardiac pericytes. (2020) (12)
Acute Myocarditis Associated With Desmosomal Gene Variants. (2022) (12)
Systolic blood pressure target in systemic arterial hypertension: Is lower ever better? Results from a community-based Caucasian cohort. (2017) (12)
External validation of the HCM Risk-Kids model for predicting sudden cardiac death in childhood hypertrophic cardiomyopathy (2021) (12)
Isocapnic buffering period: From physiology to clinics (2019) (12)
Value of Strain Imaging and Maximal Oxygen Consumption in Patients With Hypertrophic Cardiomyopathy. (2017) (12)
The Impact of Diabetes on Early Outcomes after Routine Bilateral Internal Thoracic Artery Grafting. (2016) (12)
Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator (2022) (12)
Usefulness of Addition of Magnetic Resonance Imaging to Echocardiographic Imaging to Predict Left Ventricular Reverse Remodeling in Patients With Nonischemic Cardiomyopathy. (2018) (12)
Dose-dependent efficacy of β-blocker in patients with chronic heart failure and atrial fibrillation. (2018) (12)
Sacubitril/Valsartan: Updates and Clinical Evidence for a Disease-Modifying Approach (2019) (12)
The evolving care of the elderly with heart failure: from the ‘high-tech’ to the ‘high-touch’ approach (2006) (12)
Heart transplantation in Kearns-Sayre syndrome. (2019) (12)
Genetic factors in dilated cardiomyopathy. (1996) (11)
Off-target effects of thrombolytic drugs: apolipoprotein A-I proteolysis by alteplase and tenecteplase. (2013) (11)
[Dilated cardiomyopathy: a dynamic disease - clinical course, reverse remodeling and prognostic stratification]. (2016) (11)
Genetic bases of dilated cardiomyopathy. (2017) (11)
Unexplained Double‐Chambered Left Ventricle Associated with Contracting Right Ventricular Aneurysm and Right Atrial Enlargement (2014) (11)
Choosing among β-blockers in heart failure patients according to β-receptors' location and functions in the cardiopulmonary system. (2020) (11)
Association of Titin Variations With Late-Onset Dilated Cardiomyopathy. (2022) (11)
The challenge of cardiomyopathies in 2007 (2008) (11)
Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry (2020) (11)
Preoperative Intra-Aortic Counterpulsation in Cardiac Surgery: Insights From a Retrospective Series of 588 Consecutive High-Risk Patients. (2017) (11)
Trial-generated profiles for implantation of electrical devices in outpatients with heart failure: real-world prevalence and 1-year outcome. (2010) (11)
Non-invasive Estimation of Right Atrial Pressure Using Inferior Vena Cava Echography. (2019) (11)
Prospective validation of a predictive scoring system for deep sternal wound infection after routine bilateral internal thoracic artery grafting. (2016) (11)
Is bilateral internal thoracic artery grafting a safe option for chronic dialysis patients? (2017) (10)
Left ventricular diastolic filling pattern at Doppler echocardiography and apoptotic rate in fatal acute myocardial infarction. (2007) (10)
Long term survival in patients with cardiac amyloidosis. Prevalence and characterisation during follow-up. (2013) (10)
Combined Role of Troponin and Natriuretic Peptides Measurements in Patients With Covid-19 (from the Cardio-COVID-Italy Multicenter Study) (2022) (10)
HF progression among outpatients with HF in a community setting. (2019) (10)
Mineralocorticoid receptor antagonists for heart failure: a real‐life observational study (2018) (10)
The Risk of Neurological Dysfunctions after Deep Hypothermic Circulatory Arrest with Retrograde Cerebral Perfusion. (2017) (10)
Restrictive left ventricular filling pattern in dilated cardiomyopathy: Clinical, hemodynamic and prognostic implications (2006) (10)
Insight into genetic determinants of resting heart rate. (2014) (10)
Characterization and Long-Term Prognosis of Postmyocarditic Dilated Cardiomyopathy Compared With Idiopathic Dilated Cardiomyopathy. (2016) (10)
Routine use of bilateral internal thoracic artery grafting in women: A risk factor analysis for poor outcomes. (2017) (10)
Guide extension, unmissable tool in the armamentarium of modern interventional cardiology. A comprehensive review. (2016) (10)
Galectin 3 and Galectin 3 Binding Protein Improve the Risk Stratification after Myocardial Infarction (2019) (10)
Italian Cardiological Guidelines (COCIS) for Competitive Sport Eligibility in athletes with heart disease: update 2020. (2021) (9)
Long-term evolution of right ventricular dysplasia-cardiomyopathy. The Heart Muscle Disease Study Group. (1995) (9)
Exercise performance, haemodynamics, and respiratory pattern do not identify heart failure patients who end exercise with dyspnoea from those with fatigue† (2017) (9)
Atrial thrombi or cardiac tumours? The image-challenge of intracardiac masses: a case report (2020) (9)
Chest pain and ST elevation: not always ST-segment-elevation myocardial infarction. (2010) (9)
Molecular and Cellular Mechanisms in Heart Failure (2018) (9)
Remodeling of dystrophin and sarcomeric Z-band occurs in pediatric cardiomyopathies: a unifying mechanism for force transmission defect (2009) (9)
Nonpredictive value of fibrosis in dilated cardiomyopathy treated with metoprolol. (1996) (9)
‘PERFSCORE’ – a multidimensional score: a simple way to predict the success of cardiac rehabilitation (2017) (9)
Heart failure and personalized medicine (2011) (9)
Prognostic role of global longitudinal strain by feature tracking in patients with hypertrophic cardiomyopathy: The STRAIN-HCM study. (2021) (9)
Arrhythmic risk stratification by cardiac magnetic resonance tissue characterization: disclosing the arrhythmic substrate within the heart muscle (2020) (9)
The role of implantable cardioverter defibrillator for primary vs secondary prevention of sudden death in patients with idiopathic dilated cardiomyopathy. (2004) (9)
The alveolar to arterial oxygen partial pressure difference is associated with pulmonary diffusing capacity in heart failure patients (2016) (9)
[Clinical polymorphic presentation and natural history of active myocarditis: experience in 60 cases]. (1997) (9)
Double versus single source left-sided coronary revascularization using bilateral internal thoracic artery graft alone (2018) (9)
Impact on clinical outcomes of right ventricular response to percutaneous correction of secondary mitral regurgitation (2021) (9)
Pulmonary hypertension and pregnancy outcomes: data from the Registry Of Pregnancy and Cardiac Disease (ROPAC) of the European Society of Cardiology (2017) (8)
High prevalence of subtle systolic and diastolic dysfunction in genotype-positive phenotype-negative relatives of dilated cardiomyopathy patients. (2020) (8)
Effects of the COVID-19 pandemic on the formation of fellows in training in cardiology (2021) (8)
Relative survival in dilated cardiomyopathy: a stratification study of long-term outcome to evaluate life insurance cover. (2009) (8)
Clinical Features and Natural History of Preadolescent Nonsyndromic Hypertrophic Cardiomyopathy (2022) (8)
Validation of a Predictive Scoring System for Deep Sternal Wound Infection after Bilateral Internal Thoracic Artery Grafting in a Cohort of French Patients. (2017) (8)
Idiopathic dilated cardiomyopathy: prognostic significance of electrocardiographic and electrophysiologic findings in the nineties. (2004) (8)
Conflicting gender-related differences in the natural history of patients with Idiopathic Dilated Cardiomyopathy (2017) (8)
Asymmetric ring annuloplasty for ischemic mitral regurgitation: early and mid-term outcomes. (2014) (8)
Outcome of the multidimensional prognostic index in ultra-octogenarian patients hospitalized for cardiovascular diseases (2018) (8)
COVID-19 impact on ST-elevation myocardial infarction incidence rate in a north-eastern Italian STEMI network: a U-shaped curve phenomenon. (2021) (8)
Prognostic Value of Global Longitudinal Strain-Based Left Ventricular Contractile Reserve in Candidates for Percutaneous Correction of Functional Mitral Regurgitation: Implications for Patient Selection. (2019) (8)
From Brain to Heart: Possible Role of Amyloid-β in Ischemic Heart Disease and Ischemia-Reperfusion Injury (2020) (8)
Speeding up coeliac disease diagnosis in cardiological settings (2010) (8)
MIRACLE2 Score and SCAI Grade to Identify Patients With Out-of-Hospital Cardiac Arrest for Immediate Coronary Angiography. (2022) (8)
Purulent pericarditis in rheumatoid arthritis treated with rituximab and methotrexate. (2014) (8)
The natural history of dilated cardiomyopathy: how has it changed? (2017) (8)
Effects of Candesartan on Left Ventricular Function, Aldosterone and BNP in Chronic Heart Failure (2012) (8)
Global Right Heart Assessment with Speckle-Tracking Imaging Improves the Risk Prediction of a Validated Scoring System in Pulmonary Arterial Hypertension. (2020) (8)
Rapid Exclusion of COVID Infection With the Artificial Intelligence Electrocardiogram (2021) (8)
Left ventricular adverse remodeling after myocardial infarction and its association with vitamin D levels. (2019) (8)
Radiotherapy and risk of implantable cardioverter-defibrillator malfunctions: experimental data from direct exposure at increasing doses (2018) (8)
Impact of patient delay in a modern real world STEMI network. (2020) (7)
Sex-Specific Prognostic Implications in Dilated Cardiomyopathy After Left Ventricular Reverse Remodeling (2020) (7)
Low QRS Voltages in Cardiac Amyloidosis (2022) (7)
Ghrelin Derangements in Idiopathic Dilated Cardiomyopathy: Impact of Myocardial Disease Duration and Left Ventricular Ejection Fraction (2019) (7)
Discovering patterns of pleiotropy in genome-wide association studies (2018) (7)
Integrated Outpatient Care in Advanced Heart Failure: the Beehive Person-Centered Model (2014) (7)
Assessment of Phasic Changes of Vascular Size by Automated Edge Tracking-State of the Art and Clinical Perspectives (2022) (7)
Clinical Presentation and Evolution in Treated and Untreated Myocarditis (1990) (7)
The fate of patients having deep sternal infection after bilateral internal thoracic artery grafting in the negative pressure wound therapy era. (2018) (7)
Risk stratification in cardiomyopathy (2020) (7)
Biomarkers in the management of acute heart failure: state of the art and role in COVID‐19 era (2021) (7)
Exploring the possible link between myocarditis and mRNA COVID-19 vaccines (2021) (7)
Arrhythmic risk stratification in patients with dilated cardiomyopathy and intermediate left ventricular dysfunction (2019) (7)
Syncope in a patient presenting to the emergency room with chest pain, shock, and neurological disorders. (2007) (7)
Mitral annuloplasty with IMR ETlogix ring for ischemic mitral regurgitation and left ventricular dysfunction. (2012) (7)
Adherence to Disease-Modifying Therapy in Patients Hospitalized for HF: Findings from a Community-Based Study (2019) (7)
Global Longitudinal Strain is Incremental to Left Ventricular Ejection Fraction for the Prediction of Outcome in Optimally Treated Dilated Cardiomyopathy Patients (2022) (7)
Lamin A/C Cardiomyopathy: Cutting Edge to Personalized Medicine. (2017) (7)
Sex differences among patients with transthyretin amyloid cardiomyopathy – from diagnosis to prognosis (2022) (7)
Do rebreathing manoeuvres for non-invasive measurement of cardiac output during maximum exercise test alter the main cardiopulmonary parameters? (2019) (7)
Clinical application of CMR in cardiomyopathies: evolving concepts and techniques (2022) (7)
Administrative database, observational research and the Tower of Babel. (2019) (6)
Deleterious impact of mild anemia on survival of young adult patients (age 45 ± 14 years) with idiopathic dilated cardiomyopathy: data from the Trieste Cardiomyopathies Registry. (2011) (6)
Cardiovascular aging: the unveiled enigma from bench to bedside (2018) (6)
Transient versus persistent improved ejection fraction in non‐ischaemic dilated cardiomyopathy (2022) (6)
Long-term oral carvedilol in chronic heart failure (2004) (6)
MitraClip after heart transplantation: A case report. (2015) (6)
Genetics of Dilated Cardiomyopathy: Current Knowledge and Future Perspectives (2019) (6)
Microvascular heart involvement in systemic autoimmune diseases: The purinergic pathway and therapeutic insights from the biology of the diseases. (2019) (6)
Long-term prognostic role of diabetes mellitus and glycemic control in heart failure patients with reduced ejection fraction. (2020) (6)
[The prognostic assessment of dilated cardiomyopathy: a follow-up of 138 patients]. (1990) (6)
Antiarrhythmic therapy and risk of cumulative ventricular arrhythmias in arrhythmogenic right ventricle cardiomyopathy. (2021) (6)
The alcohol-induced cardiomyopathy: A cardiovascular magnetic resonance characterization. (2021) (6)
Congenital heart disease in the ESC EORP Registry of Pregnancy and Cardiac disease (ROPAC) (2021) (6)
Restrictive cardiomyopathy: definition and diagnosis (2022) (6)
Clinical Risk Score to Predict Pathogenic Genotypes in Patients With Dilated Cardiomyopathy. (2022) (6)
Endomyocardial biopsy in the clinical context: current indications and challenging scenarios (2022) (6)
Left Ventricular Response to Cardiac Resynchronization Therapy: Insights From Hemodynamic Forces Computed by Speckle Tracking (2019) (6)
Diabetes Mellitus and Vitamin D Deficiency: Comparable Effect on Survival and a Deadly Association after a Myocardial Infarction (2020) (6)
Value of the HFA‐PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis (2022) (6)
Cardiac fluid dynamics meets deformation imaging (2018) (6)
Cardiac tamponade: an unusual, fatal complication of infective endocarditis. (1999) (6)
The genetic architecture of Plakophilin 2 cardiomyopathy (2021) (6)
Long-term patient satisfaction with implanted device remote monitoring: a comparison among different systems. (2019) (6)
Clinical Validation of a Coronary Surgery Technique That Minimizes Aortic Manipulation. (2019) (6)
Evolution of tricuspid regurgitation after transcatheter edge‐to‐edge mitral valve repair for secondary mitral regurgitation and its impact on mortality (2022) (6)
NT-proBNP level before primary PCI and risk of poor myocardial reperfusion: insight from the On-Time II trial. (2020) (5)
Targeted Approach to Distinguish and Determine Absolute Levels of GDF8 and GDF11 in Mouse Serum (2020) (5)
Combining New Classes of Drugs for HFrEF: from Trials to Clinical Practice. (2021) (5)
Traditional and Emerging Biomarkers in Asymptomatic Left Ventricular Dysfunction—Promising Non-Coding RNAs and Exosomes as Biomarkers in Early Phases of Cardiac Damage (2021) (5)
Prognostic impact of the updated 2018 HFA‐ESC definition of advanced heart failure: results from the HELP‐HF registry (2022) (5)
Metoprolol-induced functional benefit in dilated cardiomyopathy is sustained over four years and favorably influences outcome. (2001) (5)
Genetic analyses of the electrocardiographic QT interval and its components identify additional loci and pathways (2022) (5)
Cardioprotective factors against myocardial infarction selected in vivo from an AAV secretome library (2022) (5)
Urgent Coronary Revascularization with Bilateral Internal Thoracic Artery Grafting: Is the Risk Justified? (2016) (5)
Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19 (2021) (5)
Correction to: SARS‑CoV‑2, myocardial injury and inflammation: insights from a large clinical and autopsy study (2021) (5)
Dilated Cardiomyopathy With Mid‐Range Ejection Fraction at Diagnosis: Characterization and Natural History (2019) (5)
Activation of PDGFRA signaling contributes to filamin C–related arrhythmogenic cardiomyopathy (2022) (5)
Genetic Cardiomyopathies. A Clinical Approach (2012) (5)
Echocardiographic Advances in Dilated Cardiomyopathy (2021) (5)
Effects of carvedilol on LV function and remodeling in patients with dilated cardiomyopathy with persistent LV dysfunction despite optimal conventional therapy (1998) (5)
[Classification of cardiomyopathies]. (1999) (5)
Early occurrence of drug intolerance as risk factor during follow-up in patients with acute coronary syndrome or coronary revascularization (2018) (5)
[Myocarditis and pericarditis following mRNA COVID-19 vaccination. Expert opinion of the Italian Society of Cardiology]. (2021) (5)
[Dilated cardiomyopathy: etiology, clinical criteria for diagnosis and screening of the familial form]. (2002) (5)
Impact of Earlier Diagnosis in Cardiac ATTR Amyloidosis Over the Course of 20 Years (2022) (5)
Prognostic Role of Left Ventricular Dysfunction in Patients With Coronary Artery Disease After an Ambulatory Cardiac Rehabilitation Program. (2019) (5)
Right ventricular dysfunction in right coronary artery infarction: A primary PCI registry analysis. (2020) (5)
Influence of ageing on circadian rhythm of heart rate variability in healthy subjects. (2020) (5)
Standardizing the role of EMB in current clinical practice worldwide. (2021) (5)
Dilated cardiomyopathy (2019) (5)
[Hospital statistics as tool in epidemiologic studies: heart failure in Trieste]. (2002) (5)
Prognostic Significance of Feature-Tracking Right Ventricular Global Longitudinal Strain in Non-ischemic Dilated Cardiomyopathy (2021) (5)
HRV spectral and fractal analysis in heart failure patients with different aetiologies (2014) (5)
Modifications of medical treatment and outcome after percutaneous correction of secondary mitral regurgitation (2020) (5)
Prevalence and evolution of right ventricular dysfunction among different genetic backgrounds in dilated cardiomyopathy. (2021) (5)
Prognostic impact of short‐term changes of E/E' ratio and left atrial size in dilated cardiomyopathy (2019) (5)
Bilateral coronary obstruction in high-risk transcatheter aortic valve-in-valve implantation: When procedural strategy counts. (2016) (5)
Right ventricular function assessed by cardiac magnetic resonance predicts the response to resynchronization therapy. (2020) (4)
Factor-V HR2 haplotype and thromboembolic disease. (2015) (4)
Aortic-right atrium fistula complicating Austrian Syndrome: a case report and literature review. (2007) (4)
Clinical aspects and haemodynamics in the follow-up of dilated cardiomyopathy and myocarditis. (1991) (4)
Comparative evaluation of B-type natriuretic peptide and mid-regional pro-A-type natriuretic peptide changes from admission to discharge in prognosis of acute decompensated heart failure patients. (2012) (4)
Cardiac hamartoma (2018) (4)
Clinical and echocardiographic predictors of long-term outcome of a large cohort of patients with bicuspid aortic valve (2017) (4)
CARDIOVASCULAR DEATH RISK IN RECOVERED MID-RANGE EJECTION FRACTION HEART FAILURE: INSIGHTS FROM CARDIOPULMONARY EXERCISE TEST. (2020) (4)
Nonatherosclerotic Coronary Artery Narrowing. (2016) (4)
Detection of subjects with ischemic heart disease by using machine learning technique based on heart rate total variability parameters (2020) (4)
Contemporary etiology and prognosis of dilated non-ischemic cardiomyopathy. (2021) (4)
Prevalence of risk of thrombosis and of bleeding and antithrombotic treatment in patients with heart failure (2020) (4)
Perioperative Critical Care Cardiology (2007) (4)
Lyme Carditis: From Pathophysiology to Clinical Management (2022) (4)
Natural History of Idiopathic Dilated Cardiomyopathy (1993) (4)
The (ultra) sound of a burning heart: A matter of speckles. (2018) (4)
Factor-V HR2 haplotype and thromboembolic disease (2015) (4)
Role of the electrocardiogram in differentiating genetically determined dilated cardiomyopathy from athlete's heart (2022) (4)
Fatal Immunodeficiency in a Patient with Thymoma and Good's Syndrome (2005) (4)
Physical activity in older people: better late than never, but better early than late (2022) (4)
Resynchronization therapy in heart failure: the ‘nonresponder’ (2018) (4)
[ANMCO/SIC Consensus document on the management of myocarditis]. (2020) (4)
Evidence of a double anaerobic threshold in healthy subjects. (2021) (4)
Prevalence, characteristics and outcomes of older patients with hereditary versus wild‐type transthyretin amyloid cardiomyopathy (2023) (4)
Tafazzin gene mutations are uncommon causes of dilated cardiomyopathy in adults (2011) (4)
Coronary fistula of the left main artery draining in the right atrium and associated aorto-right atrial fistula. (2014) (4)
OLD AND NEW EQUATIONS FOR MAXIMAL HEART RATE PREDICTION IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION ON BETA-BLOCKERS TREATMENT. RESULTS FROM THE MECKI SCORE DATASET. (2022) (4)
Transcatheter closure of left ventricular apical pseudoaneurysm with an amplatzer vascular plug. (2019) (4)
Is heart failure with preserved ejection fraction a ‘dementia’ of the heart? (2021) (4)
Effect of prehospital treatment in STEMI patients undergoing primary PCI (2022) (4)
Risk of sudden cardiac death in New York Heart Association class I patients with dilated cardiomyopathy: A competing risk analysis. (2020) (4)
Preserved Skeletal Muscle Mitochondrial Function, Redox State, Inflammation and Mass in Obese Mice with Chronic Heart Failure (2020) (4)
Inferior Vena Cava Edge Tracking Echocardiography: A Promising Tool with Applications in Multiple Clinical Settings (2022) (3)
Appropriateness, inappropriateness and waste of resources: Unfulfilled expectations? (2019) (3)
236. Delivery of VEGF Using AAV Vectors Stimulates Skeletal Muscle Regeneration In Vivo (2004) (3)
Tissue Doppler indices of diastolic function as prognosticator in patients without heart failure in primary care. (2020) (3)
ICD replacement in patients with intermediate left ventricular dysfunction under optimal medical treatment. (2019) (3)
LONG-TERM PERSISTENT IMPROVEMENT IN PATIENTS WITH DILATED CARDIOMYOPATHY TREATED WITH METOPROLOL (1995) (3)
[Echocardiographic follow-up of patients with heart failure. Which parameters should be measured? How often?]. (2000) (3)
[How the natural history of dilated cardiomyopathy has changed. Review of the Registry of Myocardial Diseases of Trieste]. (2004) (3)
Optical coherence tomography for strategy planning and staged optimization of spontaneous coronary artery dissection. (2017) (3)
Old and Novel Therapeutic Approaches in the Management of Hyperglycemia, an Important Risk Factor for Atherosclerosis (2022) (3)
The evolution of cardiology: changes, future challenges and opportunities. (2017) (3)
Late Gadolinium Enhancement–Dispersion Mapping (2020) (3)
One-Year Risk of Myocarditis After COVID-19 Infection: A Systematic Review and Meta-analysis (2022) (3)
[Achieving optimal cholesterol levels in patients with chronic ischemic heart disease: from guidelines to the real world]. (2015) (3)
Impact of Aging on Heart Rate Variability Properties of Healthy Subjects (2015) (3)
Historical Terminology, Classifications, and Present Definition of DCM (2019) (3)
Renin-angiotensin-aldosterone system inhibition in patients affected by heart failure: efficacy, mechanistic effects and practical use of sacubitril/valsartan. Position Paper of the Italian Society of Cardiology. (2022) (3)
Clinical characterization and natural history of chemotherapy‐induced dilated cardiomyopathy (2022) (3)
The eight-shaped heart: an incidental giant left ventricular pseudoaneurysm. (2015) (3)
Common Shared Pathogenic Aspects of Small Vessels in Heart and Brain Disease (2022) (3)
[Peripartum cardiomyopathy: clinical, echocardiographic and biopsy aspects]. (1990) (3)
Hat-Marker Orientation to Minimize Neo-Commissural Overlap With Coronaries During CoreValve Evolut Transcatheter Aortic Valve Replacement. (2020) (3)
Corrigendum to “The role of implantable cardioverter defibrillator for primary vs secondary prevention of sudden death in patients with idiopathic dilated cardiomyopathy” [Europace 2004;6:400–406] (2005) (3)
[ANMCO/SICI-GISE/SIC/SIECVI/SIRM Consensus document: Appropriateness of multimodality imaging in cardiovascular disease]. (2020) (3)
A big - data classification tree for decision support system in the detection of dilated cardiomyopathy using heart rate variability (2020) (3)
Left bundle branch block in dilated cardiomyopathy with intermediate left ventricular dysfunction: Clinical phenotyping and outcome correlates. (2019) (3)
Supraventricular Tachycardia Causing Left Ventricular Dysfunction. (2021) (3)
Echocardiographic and Doppler Findings in Primary Sarcoma of the Pulmonary Artery (1992) (3)
Prevalence, clinical and instrumental features of left bundle branch block‐induced cardiomyopathy: the CLIMB registry (2021) (3)
Management of nonischemic-dilated cardiomyopathies in clinical practice: a position paper of the working group on myocardial and pericardial diseases of Italian Society of Cardiology. (2020) (3)
Prognostic Prediction of Genotype vs Phenotype in Genetic Cardiomyopathies. (2022) (3)
Clinical echocardiography and other imaging techniques in cardiomyopathies (2014) (3)
Noncoding RNAs in Cardiovascular Disease (2019) (3)
Global longitudinal strain by CMR improves prognostic stratification in acute myocarditis presenting with normal LVEF (2021) (3)
Evolution of left ventricular sphericity index in idiopathic dilated cardiomyopathy: clinical and prognostic implications (2013) (3)
[Heart failure due to diastolic dysfunction: the treatment principles]. (2000) (3)
Aortic root replacement with a stented bioprosthetic valved conduit: mid-term results. (2013) (3)
Light-chain cardiac amyloidosis: a case report of extraordinary sustained pathological response to cyclophosphamide, bortezomib, and dexamethasone combined therapy (2022) (3)
Re-Definition of the Epidemiology of Cardiac Amyloidosis (2022) (3)
Changes in Right Ventricular-to-Pulmonary Artery Coupling After Transcatheter Edge-to-Edge Repair in Secondary Mitral Regurgitation. (2022) (3)
Routine use of bilateral internal thoracic artery grafting in women does not increase in-hospital mortality and could improve long-term survival. (2018) (3)
Dilated Cardiomyopathy: A Paradigm of Revolution in Medicine (2020) (3)
Gender medicine in dilated cardiomyopathy: pride and prejudice (2018) (3)
Focus on arrhythmogenic right ventricular cardiomyopathy (2020) (3)
Dilated cardiomyopathy and muscular dystrophies: which lesson can be learned? (1999) (3)
Liberal bilateral internal thoracic artery use in people with diabetes neutralizes the negative impact of insulin-requiring status (2017) (3)
Association of Premature Ventricular Contraction Burden on Serial Holter Monitoring With Arrhythmic Risk in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy. (2022) (3)
Effect of early tirofiban administration on N‐terminal pro‐B‐type natriuretic peptide level in patients treated with primary percutaneous coronary intervention (2018) (3)
Cardiovascular risk management in type 2 diabetes mellitus: A joint position paper of the Italian Cardiology (SIC) and Italian Diabetes (SID) Societies. (2021) (3)
[Improvement of prognosis in idiopathic dilated cardiomyopathy: role of early diagnosis and optimized medical treatment. Study Group on Heart Muscle Diseases]. (1999) (3)
[The SHIFT study]. (2011) (3)
HRV Analysis in CHF Patients with Different Etiologies by Means of Spectral and Nonlinear Indexes (2015) (3)
Reversal of angiodysplasia-derived anemia after transcatheter aortic valve implantation. (2012) (3)
From mid-range to mildly reduced ejection fraction heart failure: A call to treat. (2022) (3)
Hypertrophic restrictive cardiomyopathy with apical thinning: a peculiar case of genotype-phenotype correlation. (2017) (3)
Three-vessel coronary artery disease evaluation by multimodality imaging with near-infrared spectroscopy (NIRS) plus intravascular ultrasound (IVUS) and optical coherence tomography (OCT). (2015) (2)
Influence of Aging on Short- and Long-Term Heart Rate Variability in Patients with Heart Failure (2016) (2)
659 Prognostic importance of anemia in very elderly patients with heart failure on optimized therapy (2005) (2)
The Diagnosis of Acute Myocarditis in Emergency (DAME) score: improving diagnostics within the emergency department. (2021) (2)
Right Ventricular Strain and Dyssynchrony Assessment in Arrhythmogenic Right Ventricular Cardiomyopathy: A Cardiac Magnetic Resonance Feature-Tracking Study (2016) (2)
STEMI and Multivessel Disease: Medical Therapy Amplifies the Benefit of Complete Myocardial Revascularisation. (2021) (2)
Patient adherence to drug treatment in a community based-sample of patients with chronic heart failure. (2021) (2)
[2022 Update on myocarditis and pericarditis following COVID-19 vaccination. Expert Opinion of the Italian Society of Cardiology]. (2022) (2)
[New evidences on the use of aldosterone receptor antagonists in left ventricular dysfunction: from myocardial infarction to heart failure]. (2012) (2)
[Dilated cardiomyopathy: indication and role of endomyocardial biopsy]. (2002) (2)
A life-threatening manifestation of tachycardia-induced cardiomyopathy. (2014) (2)
The response to cardiac resynchronization therapy in LMNA cardiomyopathy (2022) (2)
Do Pharmacological Differences Among Beta-Blockers Affect Their Clinical Efficacy in Heart Failure? (2004) (2)
Case Report: Cardiac Involvement by Lymphoma: Rare but Heterogeneous Condition With Challenging Behaviors (2021) (2)
Acromegalic Cardiomyopathy With Malignant Arrhythmogenic Pattern Successfully Treated With Mechanical Circulatory Support and Heart Transplantation. (2017) (2)
Chemoreceptor hyperactivity in heart failure: Is lactate the culprit? (2020) (2)
Hospital-to-Community Integrated Pathways for Heart Failure: critical aspects and future prospectives (2014) (2)
The right ventricular involvement in dilated cardiomyopathy: prevalence and prognostic implications of the often-neglected child (2022) (2)
[Effectiveness of the Palmaz Schatz stent in elderly patients with unstable angina: factors predictive of short-term and long-term events]. (1997) (2)
The impossible interviews—Sherlock Holmes interviews David Sackett: ‘how much can we trust the guidelines?’ (2021) (2)
Infiltrative/Storage Cardiomyopathies: Clinical Assessment and Imaging in Diagnosis and Patient Management (2014) (2)
Machine learning for prediction of in-hospital mortality in coronavirus disease 2019 patients: results from an Italian multicenter study (2022) (2)
Complex Ventricular Arrhythmias in Dilated Cardiomyopathy: A Multicenter Italian Experience (1990) (2)
Familial dilated cardiomyopathy with subclinical skeletal muscle involvement (1996) (2)
Toward a diagnostic CART model for Ischemic heart disease and idiopathic dilated cardiomyopathy based on heart rate total variability (2022) (2)
Lipid-Lowering Drug Therapy: Critical Approach for Implementation in Clinical Practice (2021) (2)
Sex-related differences in patients with coronavirus disease 2019: results of the Cardio-COVID-Italy multicentre study (2022) (2)
Regenerative Medicine and Biomarkers for Dilated Cardiomyopathy (2019) (2)
[Ambulatory cardiac rehabilitation in Trieste: protocols of intervention, activities and outcomes]. (2017) (2)
The Role of Clinical Observation: Red Flag 5 — Right Ventricular Involvement, Arrhythmogenic Right Ventricular Cardiomyopathy and Associated Phenotypes (2013) (2)
Direct cellular reprogramming: the hopes and the hurdles (2016) (2)
Left ventricular reverse remodeling prediction in non-ischemic cardiomyopathy: present and perspectives (2018) (2)
Prognosis and mechanism of death in treated heart failure: data from the placebo arm of Val-HeFT. (2006) (2)
Right ventricular strain is a stronger predictor of prognosis than left ventricular analysis in patients referred for heart transplantation (2012) (2)
Identification of Ischemic Heart Disease by using machine learning technique based on parameters measuring Heart Rate Variability (2020) (2)
MicroRNA therapy stimulates uncontrolled cardiac repair after myocardial infarction in pigs (2019) (2)
Prognostic significance of longitudinal strain in dilated cardiomyopathy with recovered ejection fraction (2021) (2)
[The classification of cardiomyopathies]. (1998) (2)
Association between implantable defibrillator‐detected sleep apnea and atrial fibrillation: The DASAP‐HF study (2022) (2)
Atrial signal amplitude predicts atrial high‐rate episodes in implantable cardioverter defibrillator patients: Insights from a large database of remote monitoring transmissions (2020) (2)
Echocardiographic evaluation of centenarians in Trieste (2020) (2)
Left ventricular thrombectomy in myocarditis: the epicardial scan & video-assisted transaortic approach (2018) (2)
Prognostic relevance of pericardial effusion in STEMI patients treated by primary percutaneous coronary intervention: a 10-year single-centre experience. (2019) (2)
Left ventricular function and exercise performance in idiopathic dilated cardiomyopathy: role of tissue Doppler imaging (2017) (2)
The Role of Exercise-Induced Molecular Processes and Vitamin D in Improving Cardiorespiratory Fitness and Cardiac Rehabilitation in Patients With Heart Failure (2022) (2)
Takotsubo: One, no one and one hundred thousand diseases. (2018) (2)
Long-term effect of SARS-CoV-2 infection on cardiovascular outcomes and all-cause mortality (2022) (2)
[Changes in medical treatment of heart failure in the light of large clinical trials]. (2001) (2)
Impact of abciximab on prognosis in diabetic patients undergoing primary percutaneous coronary intervention (2013) (2)
Roles of periodic breathing and isocapnic buffering period during exercise in heart failure (2020) (2)
[Cardiac contractility modulation in heart failure with reduced ejection fraction: critical review of evidence and application perspectives]. (2021) (2)
IMPACT OF HYPERGLYCEMIA ON CLINICAL OUTCOME IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI) FOR ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (STEMI) (2008) (2)
Cardiac Contractility Modulation in Patients with Heart Failure with Reduced Left Ventricular Ejection Fraction (2021) (2)
Pick your threshold: a comparison among different methods of anaerobic threshold evaluation in heart failure prognostic assessment. (2022) (2)
Complex MitraClip procedure for a complex patient: the challenge of commissural flail. (2019) (2)
[Work-up and management of constrictive pericarditis: a critical review]. (2016) (2)
Sex differences in natural history of cardiovascular magnetic resonance‐ and biopsy‐proven lymphocytic myocarditis (2022) (2)
Inflammation in cardiac amyloidosis: prognostic marker or therapeutic target? (2018) (2)
Acute inflammatory cardiomyopathy: apparent neutral prognostic impact of immunosuppressive therapy (2020) (2)
Disseminated echinococcosis: follow your heart. (2016) (2)
Ultrafiltration in decompensated heart failure: Is time to look forward? (2022) (2)
[Palliative care in the cardiac setting: a consensus document of the Italian Society of Cardiology/Italian Society of Palliative Care (SIC/SICP)]. (2019) (2)
Prognostic value of echocardiographic evaluation of cardiac mechanics in patients with aortic stenosis and preserved left ventricular ejection fraction (2022) (2)
[Nonvalvular atrial fibrillation: data from the Observatory of Cardiovascular Diseases in the province of Trieste (Italy)]. (2015) (2)
Prognostic value of implantable defibrillator-computed respiratory disturbance index: The DASAP-HF study. (2020) (2)
[Disease management system in patients with chronic heart failure]. (2007) (2)
Evidence-based Therapy in Older Patients with Heart Failure with Reduced Ejection Fraction (2022) (2)
Pulmonary artery aneurysm and sarcoidosis. (2015) (2)
Combined orthotopic heart transplantation followed by autologous stem cell transplantation in a patient with light chain amyloidosis and isolated cardiac involvement (2018) (1)
Reshaping care in the aftermath of the pandemic. Implications for cardiology health systems (2022) (1)
New insights into the genetics of dilated cardiomyopathy (1997) (1)
Sudden cardiac death in cardiomyopathies: acting upon “acceptable” risk in the personalized medicine era (2022) (1)
AL CARDIAC AMYLOIDOSIS - A CASE REPORT OF EXTRAORDINARY SUSTAINED PATHOLOGICAL RESPONSE TO CYBORD THERAPY (2022) (1)
Late improvement of left ventricular ejection fraction in patients with persistent severe systolic dysfunction under guideline-directed medical therapy (2021) (1)
A 20-year experience in cardiac tumors: a single center surgical experience and a review of literature (2022) (1)
Cardiac Magnetic Resonance in Primary Prevention of Sudden Cardiac Death (2019) (1)
Molecular diagnosis of opportunistic pericardial infection in a patient treated with adalimumab: the role of next-generation sequencing (2016) (1)
Exercise capacity in patients with hypertrophic cardiomyopathy: non-invasive hemodynamic responses to exercise and association with clinical and imaging variables (2013) (1)
P6589Genetic risks for arrhythmia phenotypes in dilated cardiomyopathy (2019) (1)
Genetic Loci In fl uencing Myocardial Mass (2016) (1)
[Hyperkalemia in heart failure: new solutions for an old problem]. (2019) (1)
610 Frailty is an independent prognostic variable in very elderly patients with heart failure (2006) (1)
[Practical indications for successful implementation of palliative care in heart failure patients]. (2020) (1)
[Pharmacological therapy of chronic heart failure in the elderly]. (2004) (1)
Are aortic coarctation and rheumatoid arthritis different models of aortic stiffness? Data from an echocardiographic study (2018) (1)
Predictive value of heart rate in dilated cardiomyopathy treated with metoprolol. (1997) (1)
PROGNOSTIC VALUE OF A SYSTEMATIC FAMILIAL SCREENING IN IDIOPATHIC DILATED CARDIOMYOPATHY. THE EXPERIENCE OF TRIESTE HEART MUSCLE DISEASE (2010) (1)
[Beta blockers in heart failure. Experiences and recommendations for clinical use. ANMCO-Area Heart Failure]. (1998) (1)
Valsartan for prevention of recurrent atrial fibrillation (New England Journal of Medicine (2009) 360, (1606-1617)) (2009) (1)
Interchangeability of B type natriuretic peptide measurements in lithium heparin and K2EDTA: agreement between matrices and differences in diagnostic accuracy. (2011) (1)
Treatment of Functional Mitral Regurgitation in Heart Failure (2019) (1)
Left ventricular wall thickness and severity of cardiac disease in women and men with transthyretin amyloidosis (2023) (1)
[Italian Society of Cardiology (SIC) Expert consensus document: Post-acute cardiovascular sequelae of SARS-CoV-2 infection]. (2022) (1)
Advanced Heart Failure in Special Population: Cardiomyopathies and Myocarditis. (2021) (1)
Pathophysiology (2019) (1)
Long-term carvedilol treatment in idiopathic dilated cardiomyopathy: biological effects beyond pharmacological activity (2002) (1)
Vanished myxoma due to systemic embolization. (2018) (1)
Thirty-nine-year survival with the Starr-edwards mitral valve prosthesis. (2008) (1)
Are all beta blocking agents equally effective in the treatment of chronic heart failure (2000) (1)
A note on prognostic accuracy evaluation of regression models applied to longitudinal autocorrelated binary data (2014) (1)
Arrhythmogenic Right Ventricular Cardiomyopathy: Clinical Assessment and Differential Diagnosis (2014) (1)
Role of Cardiac Imaging: Echocardiography -- Dilated Cardiomyopathy: From Genetics to Clinical Management (2019) (1)
Exercise oxygen pulse kinetics in patients with hypertrophic cardiomyopathy (2022) (1)
Natural history of spontaneous coronary dissections. (2019) (1)
Arrhythmogenic cardiomyopathy with biventricular involvement and noncompaction (2016) (1)
The oldest Society of Cardiology in Italy meets the ESC. (2020) (1)
Genome-wide association meta-analysis of 30,000 samples identifies seven novel loci for quantitative ECG traits (2019) (1)
[Position paper of the Italian Society of Cardiology (SIC) on COVID-19 vaccine priority in patients with cardiovascular diseases]. (2021) (1)
Dilated Cardiomyopathy at the Crossroad: Multidisciplinary Approach (2019) (1)
Hypertrophic Cardiomyopathy: An unexpected finding in a surgical variant of Heterotopic Heart Transplantation. (2016) (1)
[The ACCLAIM trial]. (2008) (1)
A thirty-nine-year survival with the Starr-Edwards mitral valve prosthesis Trentanove anni di sopravvivenza con una protesi mitralica di Starr-Edwards (2008) (1)
PR interval genome-wide association meta-analysis identifies 50 loci associated with atrial and atrioventricular electrical activity (2018) (1)
The labyrinth of nomenclature in Cardiology. Eternal dilemmas and new challenges on the horizon in the personalized medicine era (2020) (1)
Beta-Blocker Utilization in Congestive Heart Failure: A Survey on 4408 Italian Outpatients Over the Last Two Years (1998) (1)
P1602Electrocardiographic diifferentiation between benign T wave inversion and arrhythmogenic right ventricular cardiomyopathy (2017) (1)
Exome-chip meta-analysis identifies novel loci, including ADAMTS6 associated with cardiac conduction (2018) (1)
Arrhythmias in Dilated Cardiomyopathy: Diagnosis and Treatment -- Dilated Cardiomyopathy: From Genetics to Clinical Management (2019) (1)
Right ventricular dysplasia/cardiomyopathy: what is the evolution of the disease? (1994) (1)
Leflunomide-induced pulmonary arterial hypertension: Case report and review of literature. (2022) (1)
Admission hyperglycemia and contrast induced nephropathy (2013) (1)
Compliance to MADIT and MUSTT criteria for implantable cardioverter defibrillator therapy in the pre-SCD-Heft and MADIT II era. Data from a multicenter Italian study. (2010) (1)
P448Correlation between native T1 and T2 mapping and MRI strain parameters in patients with myocarditis: a pilot study (2019) (1)
Prognostic role of exercise echocardiography in patients with hypertrophic cardiomyopathy (2013) (1)
Genetic analyses of the QT interval and its components in over 250K individuals identifies new loci and pathways affecting ventricular depolarization and repolarization (2021) (1)
[Integrated models between hospital and field for patients with heart failure]. (2002) (1)
Arrhythmogenic Right Ventricular Cardiomyopathy: Usefulness of Imaging in Prognostic Stratification and Choice of Treatment (2014) (1)
Left ventricular involvement in right ventricular cardiomyopathy. (1989) (1)
Genome-wide association meta-analysis of PR interval identifies 47 novel loci associated with atrial and atrioventricular electrical activity (2018) (1)
Abstract 11923: FLNC Gene Splice Mutation Causes Dilated Cardiomyopathy in Two Families (2014) (1)
INFLAMMASOME FORMATION IN ACUTE MYOCARDITIS (2013) (1)
CHARACTERIZATION AND LONG-TERM OUTCOME OF HYPERTENSIVE DILATED CARDIOMYOPATHY: A DISTINCT PHENOTYPE OF HYPERTENSIVE HEART DISEASE? (2013) (1)
A case of primary cardiac sarcoma with an acute presentation: The role of multimodality imaging (2021) (1)
Successful cardiac transplantation in an 11-year-old boy with ectodermal dysplasia and dilated cardiomyopathy. (2015) (1)
Echocardiographic Biventricular Coupling Index to Predict Pre-Capillary Pulmonary Hypertension. (2022) (1)
[Controversial issues and working practice in myocarditis: from scientific data to clinical grounds]. (2013) (1)
Additional value of T1 and T2 mapping techniques for early detection of myocardial involvement in scleroderma. (2023) (1)
Restrictive filling pattern in hypertrophic cardiomyopathy: Clinical significance and prognostic value (2000) (1)
Left Atrial Reverse Remodeling in Dilated Cardiomyopathy. (2022) (1)
Restrictive Cardiomyopathy: Clinical Assessment and Imaging in Diagnosis and Patient Management (2014) (1)
Long-term survival effect of metoprolol in dilated cardiomyopathy. The SPIC (Italian Multicentre Cardiomyopathy Study) Group. (1998) (1)
Prevalence and predictors of persistent sinus rhythm after elective electrical cardioversion for atrial fibrillation (2021) (1)
Does moderate hyperkalemia influence survival in HF? Insights from the MECKI score data base. (2022) (1)
Abstract 1615: Low Frequency Of Detection Of Viral Genomes In Endomyocardial Biopsies From Patients With Dilated Cardiomyopathy (2007) (1)
[Indications for cardiology consultation and management of cardiac patients who will undergo surgical or endoscopic procedures: the proposal of the University Hospital of Trieste, Italy]. (2010) (1)
Uncommon cause of ST-segment elevation in V1–V3: incremental value of cardiac magnetic resonance imaging (2014) (1)
Longitudinal arrhythmic risk assessment based on ejection fraction in patients with recent-onset non-ischemic dilated cardiomyopathy. (2022) (1)
Immunologic response and myocardial free wall rupture in infective endocarditis. (2017) (1)
Early and Late Survival of On-Pump Cardiac Surgery Patients Formerly Affected by Lymphoma. (2017) (1)
529 Heart failure etiology and long‐term response to medical treatment. The heart muscle disease registry of Triest (2003) (1)
COMPREHENSIVE STRUCTURAL AND FUNCTIONAL ASSESSMENT FOR PREDICTION OF LEFT VENTRICULAR REVERSE REMODELING IN NON-ISCHEMIC CARDIOMYOPATHY (2018) (1)
[Takotsubo and surroundings. Step by step postpartum stress-induced cardiomyopathy shows its facet. A peculiar case of atypical takotasubo in the peripartum period]. (2014) (1)
The heart of dystrophinopathies (2021) (1)
Exome-chip meta-analysis identifies novel loci associated with cardiac conduction, including ADAMTS6 (2018) (1)
554 Machine learning for prediction of in-hospital mortality in COVID-19 patients: results from an Italian multicentre study (2021) (1)
[Make a point on left ventricular noncompaction]. (2018) (1)
The impact of UEFA Euro 2020 football championship on Takotsubo Syndrome: Results of a multicenter national registry (2022) (1)
Bioresorbable vascular scaffold restenosis: intravascular imaging evaluation. (2016) (1)
PROGNOSTIC STRATIFICATION OF BIOPSY-PROVEN ACTIVE MYOCARDITIS PRESENTING WITH HEART FAILURE: ARE THERE PREDICTORS OF LONG TERM PROGNOSIS? (2010) (1)
Spielvogel and CABG one time surgery followed by TEVAR to treat thoracic aneurism and pseudoaneurysms of the arch coexisting with a three coronary artery disease. (2016) (1)
Use of social media by health care professionals: is patients' privacy respected? (2020) (1)
Early prognostic stratification and identification of irreversibly shocked patients despite primary percutaneous coronary intervention (2021) (1)
Diastolic dysfunction in cardiomyopathies (2011) (1)
What the Cardiologist Needs to Consider in the Management of Oncologic Patients with STEMI-Like Syndrome: A Case Report and Literature Review (2021) (1)
MUTATION SCREENING OF SARCOMERE GENES MYH7, MYBPC3, LDB3, AND TNNT2 IN A LARGE COHORT OF DILATED CARDIOMYOPATHY FAMILIES (2010) (1)
ECHOCARDIOGRAPHIC BIVENTRICULAR COUPLING INDEX TO PREDICT PRE-CAPILLARY PULMONARY HYPERTENSION (2021) (1)
[If heart failure or cardiac arrest complicate pregnancy and delivery]. (2010) (1)
Relationship between aortic valve stenosis and the hemodynamic pattern in the renal circulation, and restoration of the flow wave profile after correction of the valvular defect (2020) (1)
Complementary Pharmacotherapy for STEMI Undergoing Primary PCI: An Evidence-Based Clinical Approach (2022) (1)
823 Low frequency of detection of viral genomes in endomyocardial biopsies from patients with dilated cardiomyopathy (2008) (1)
The Role of Clinical Observation: Red Flag 3 — Cardiomyopathies, Wolff-Parkinson-White Syndrome and Other Electrocardiogram Abnormalities (2013) (0)
PO-1007: Neutron induced soft errors in cardiac implantable devices following radiation therapy (2015) (0)
Beta-blockers in heart failure patients with atrial fibrillation: Insights from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Pilot Registry (2016) (0)
Intravascular imaging beyond ischaemia assessment: a possible way for improving risk stratification. (2021) (0)
Clinical course of dilated cardiomyopathy in asymptomatic patients long-term treated with beta-blocking agents: the heart muscle disease registry of Trieste (2002) (0)
The changing perspective on cardiac amyloidosis in the modern era (2022) (0)
145 Is the long term outcome of familial dilated cardiomyopathy different with respect to sporadic forms (2008) (0)
[The role of ambulatory cardiac rehabilitation on return to work of patients with cardiovascular diseases]. (2019) (0)
Diagnostic Pathways to Wild-Type Transthyretin Amyloid Cardiomyopathy: a Multicenter Network Study. (2023) (0)
Epidemiology -- Dilated Cardiomyopathy: From Genetics to Clinical Management (2019) (0)
413 Challenges in the field of cardiac tumours: the surgical experience of Trieste (2021) (0)
185 Effect of carvedilol versus metoprolol immediate release on 24-hour heart rate in patients with idiopathic dilated cardiomyopathy. A 1-year cross-over study (2004) (0)
567 Comprehensive screening of human desmin (DES) gene in dilated cardiomyopathy (2005) (0)
Precision medicine in heart failure no longer a visual theory but a realistic opportunity? (2019) (0)
Iconographies supplémentaires de l'article : Long Term Survival in Patients with Cardiac Amyloidosis. Prevalence and Characterisation during Follow-up (2013) (0)
297 Echocardiographic biventricular coupling index to predict pre-capillary pulmonary hypertension (2021) (0)
Incremental prognostic value of restrictive ﬁlling pattern in hypertrophic cardiomyopathy: a Doppler echocardiographic study (2008) (0)
A case report of isolated cardiac light chain amyloidosis without clinically overt heart failure: an under-recognized presentation (2023) (0)
73 Prevalence and prognostic significance of ischaemic late gadolinium enhancement pattern in non-ischaemic dilated cardiomyopathy (2021) (0)
The Role of Clinical Observation: Red Flag 8 — Cardiomyopathies in the First Year of Life and Pediatric Cardiomyopathies (2013) (0)
An interesting case of left-to-right shunt: clues from noninvasive imaging. (2016) (0)
MiR-320a as a Potential Novel Circulating Biomarker of Arrhythmogenic CardioMyopathy (2017) (0)
Relationship Between Maximal Left Ventricular Wall Thickness and Sudden Cardiac Death in Childhood Onset Hypertrophic Cardiomyopathy (2022) (0)
Lo studio SHIFT (2011) (0)
409 The likely numbers to come: trends in hospitalisation for heart failure in the ‘sample’ town of Trieste and its region (2003) (0)
Sport and Exercise in Genotype positive (+) Phenotype negative (-) Individuals. Current Dilemmas and Future Perspectives. (2023) (0)
84 Left atrial reverse remodelling in dilated cardiomyopathy (2021) (0)
350 Effect of pre-hospital treatment for STEMI patients undergoing primary PCI (2021) (0)
12.5 Lack of role of non sustained ventricular tachycardia in predicting the risk of death in idiopathic dilated cardiomyopathy: Results from a large registry of pts with a long follow-up (2003) (0)
Managing heart failure in the very old (2006) (0)
1117 FAMILY SCREENING IN DILATED CARDIOMYOPATHY: CLINICAL CHARACTERIZATION AND FOLLOW UP OF RELATIVES (2022) (0)
Myocardial native T1 mapping and cardiac outcomes in thalassemia major (2021) (0)
Abstract 19676: A Positive Genotype Predicts Clinical Outcomes in a Large Cohort With Dilated Cardiomyopathy (2017) (0)
88 Trial‐generated patient profiles for implant with electrical devices in chronic heart failure: real‐world prevalence, outcomes and public health implications (2006) (0)
[Molecular genetic testing according to the latest European guidelines on hypertrophic cardiomyopathy]. (2015) (0)
528 Clinical correlates and prognostic value of health related quality of life measurement in chronic hearth failure (2003) (0)
398 CARDIAC MAGNETIC RESONANCE PHENOTYPE AND GENOTYPE IN LEFT-SIDED CARDIOMYOPATHIES: CHARACTERIZATION AND CLINICAL OUTCOMES (2022) (0)
Cardiology of the future: xenotransplantation with porcine heart (2022) (0)
["Dilated cardiomyopathy": an epidemic of our times]. (2009) (0)
ACE-Inhibitors, β-Blockers, Spironolactone: Do We Need Many More Drugs to Treat Chronic Heart Failure? (2003) (0)
Cardiotoxicity from Capecitabine Chemotherapy: Prospective Study of Incidence at Rest and During Physical Exercise (2022) (0)
493 A CASE REPORT OF SUBACUTE INFLAMMATORY HEART DISEASE WITH AN ATYPICAL ONSET (2022) (0)
111 Evolution of systolic and diastolic dysfunction in hypertrophic cardiomyopathy: clinical and prognostic significance (2008) (0)
Pressure–volume relationship by pharmacological stress cardiovascular magnetic resonance (2021) (0)
356 DAPAGLIFLOZIN USE IN HEART FAILURE WITH REDUCED EJECTION FRACTION PATIENTS: A SINGLE CENTRE COMPARISON BETWEEN REAL-LIFE AND DAPA-HF DATA (2022) (0)
Prognostic implications of clinical phenotype and severity of cardiac involvement in patients presenting with immunoglobulin light chain amyloidosis (2022) (0)
Inflammation on Endomyocardial Biopsy Predicts Risk of MACE in Undefined Left Ventricular Arrhythmogenic Cardiomyopathy. (2022) (0)
Trieste – CARe: Impact of adrenaline on out of hospital cardiac arrest outcome (2019) (0)
Autoptic incidence and clinical recognition of fatal myocarditis (2000) (0)
Tissue-tracking in the assessment of late gadolinium enhancement in myocarditis and myocardial infarction. (2020) (0)
Corrigendum to: Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator (2022) (0)
[The classification of cardiomyopathies: is a revision opportune?]. (1993) (0)
229Strain analysis reveals subtle systolic dysfunction in "confirmed" and "suspected" myocarditis with normal LVEF: a cardiac magnetic resonance study (2019) (0)
108 PHEOCHROMOCYTOMA-INDUCED CARDIOGENIC SHOCK: A MULTICENTRE ANALYSIS OF CLINICAL PROFILES, MANAGEMENT AND OUTCOMES (2022) (0)
[Gene therapy in heart failure: the unexpected results from the CUPID 2 trial]. (2017) (0)
132 Prognostic role of persistence of significant functional mitral regurgitation in idiopathic dilated cardiomyopathy (2008) (0)
Atlas of Endocarditis : a clinical and pathological approach (2016) (0)
Restrictive Ventricular ' Filling Pattern in Dilated Cardlomyopathy (2016) (0)
Cardiac transplantation in transthyretin amyloid cardiomyopathy: Outcomes from three decades of tertiary center experience (2022) (0)
Prognostic implications of previously known or newly diagnosed diabetes and hypovitaminosis D in patients with myocardial infarction (2020) (0)
Ventricular' Filling Pattern in Dilated Cardlomyopathy (1993) (0)
342 TMAO PLASMA LEVELS PREDICT RECURRENT ISCHEMIC EVENTS IN SURVIVORS OF MYOCARDIAL INFARCTION (2022) (0)
IS IT POSSIBLE TO PREDICT THE RESPONSE TO BETA-BLOCKER TREATMENT IN DILATED CARDIOMYOPATHY (1994) (0)
Myocarditis in Heart Failure (2014) (0)
European (jß Volume 12 Supplement D Pages 1-205 Pericardioscopy—a New Diagnostic Tool in Inflammatory Diseases of the Pericardium the Role of Pericardiectomy in Pericardial Disorders the Value of Endomyocardial Biopsies in Myocarditis and Dilated Cardiomyopathy Endomyocardial Biopsy Findings in Case (0)
Role of cardiopulmonary exercise testing in idiopathic dilated cardiomyopathy (2013) (0)
110 ANEURYSMECTOMY AND SURGICAL ABLATION: WHEN? (2022) (0)
How Coronary Perforation Looks at Optical Coherence Tomography Imaging. (2023) (0)
Chemoreceptor hyperactivity in heart failure: Is lactate the culprit? (2020) (0)
Other Cardiomyopathies: Clinical Assessment and Imaging in Diagnosis and Patient Management (2014) (0)
IDENTIFICATION OF PATIENTS WITH IDIOPATHIC DILATED CARDIOMYOPATHY WHO COULD BE CONSIDERED FOR EARLY ICD IMPLANTATION (2013) (0)
Evaluation of trial-based eligibility for device therapy in the real world: extent of the overlap between trial generated profiles and associated patients outcomes at 1 year. Poster European Congress of Cardiology 2007 (2007) (0)
196 Prognostic value of health‐related quality of life measurements in chronic heart failure (2004) (0)
An Unsuspected Case of Aortic Dissection. (2015) (0)
Debate on Cardiac Resynchronisation Therapy (2004) (0)
Abstract P1003: Mechanical Loading Controls Cardiomyocyte Proliferation (2022) (0)
Abstract 1882: Changing Proportion of Patients with Dilated Cardiomyopathy with SCDHeFT and CARE-HF/Companion Characteristics During Follow-up on Optimal Medical Treatment (2006) (0)
073_16945-L4 Severity of Heart Failure and Outcomes of Catheter Ablation of Ventricular Tachycardia in Nonischemic Dilated Cardiomyopathy (2017) (0)
Basic pathophysiology and options of treatment for surgical management of functional tricuspid regurgitation: a systematic review (2022) (0)
Contents (2020) (0)
The Arrhythmic Patient in the Emergency Department (2016) (0)
423 Prevalence and prognostic significance of atrial arrhythmias in arrhythmogenic cardiomyopathy (2021) (0)
140 Clinical and instrumental characteristics of patients with arrhythmogenic right ventricular cardiomyopathy: 30 years of experience in a referral center (2008) (0)
Gender and age normalization and ventilation ef ﬁ ciency during exercise in heart failure with reduced ejection fraction (2019) (0)
The impact of COVID-19 on myocardial infarctions, strokes and out-of-hospital cardiopulmonary arrests: an observational retrospective study on time-sensitive disorders in the Friuli Venezia Giulia region (Italy) (2022) (0)
Treatment of Supraventricular Arrhythmias by Transcatheter Radiofrequency Ablation: The Experience of the Electrophysiology Unit of the University Hospital of Trieste (2017) (0)
201 Changing proportion of patients with dilated cardiomyopathy with SCDHeFT and CARE-HF/Companion characteristics during follow-up on optimal medical treatment (2006) (0)
Aortoaxillary bypass during cardiac operation (2014) (0)
Association between Myocardial Iron Overload and Diffuse Myocardial Fibrosis in Thalassemia Major (2022) (0)
472 PROGNOSTIC VALUE OF CPET REPETITION DURING FOLLOW-UP OF DILATED CARDIOMYOPATHY (2022) (0)
116 A CASE REPORT OF ISOLATED CARDIAC LIGHT CHAIN AMYLOIDOSIS WITHOUT HEART FAILURE: AN UNDER-RECOGNISED PRESENTATION (2022) (0)
805 Educational programme based on bottom-up learning approach (2021) (0)
Cardiac imaging in heart failure in the personalized medicine era: Pathway to knowledge or Tiresias' paradox? (2021) (0)
465 Unmasking the prevalence of cardiac amyloidosis in the real world: first insights from the phase 2 of active study, an Italian nationwide survey (2021) (0)
Prognostic Impact of Functional Mitral Regurgitation Early Improvement in Patients With Idiopathic Dilated Cardiomyopathy Receiving Optimal Medical Treatment (2014) (0)
Role of Cardiac Imaging: Cardiac Magnetic Resonance and Cardiac Computed Tomography -- Dilated Cardiomyopathy: From Genetics to Clinical Management (2019) (0)
Does Ectopic Beats Bring More Discriminatory Information to Diagnose Ischemic Heart Disease? (2022) (0)
The Electrocardiogram in the Diagnosis and Management of Patients With Left Ventricular Non-Compaction (2022) (0)
[Appropriateness and surroundings: "Doing more does not mean doing better". Choosing Wisely, an unfulfilled commitment?] (2017) (0)
324 Unilateral pulmonary artery agenesis with controlateral embolism: a double vascular trouble (2021) (0)
Left ventricular force adaptation and cardiac deformation in the progression of aortic stenosis (2021) (0)
359 Transient vs. persistent improved ejection fraction in non-ischaemic dilated cardiomyopathy (2021) (0)
AB26-5: Changing proportion of patients with idiopathic dilated cardiomyopathy with SCDHeFT and CARE-HF/companion characteristics during follow-up on optimal medical treatment (2006) (0)
Thromboembolic Risk in Patients with Atrial Fibrillation: Can It Be Predicted on the Basis of Clinical Variables? (1996) (0)
Dark papillary muscles sign: a novel prognostic marker for cardiac magnetic resonance (2023) (0)
[How to optimize the treatment after acute phase: which programmes for which patients?]. (2016) (0)
Natural history of familial dilated cardiomyopathy: the heart muscle disease registry of trieste (2002) (0)
An attractive endovascular strategy for combined - aneurysmal and stenotic - coronary artery disease. (2021) (0)
[Cardiomyopathies 2008. Rethinking the issue in light of the recent American Heart Association and European Society of Cardiology statements]. (2008) (0)
293 Prevalence of organ specific autoantibodies (anti‐human‐tissue‐transglutaminase, anti‐endomysial, anti‐actin and anti‐thyreoperoxidasis antibodies) in dcm patients and their relatives (2006) (0)
Risk stratification in Arrhythmogenic Right Ventricular Cardiomyopathy: the impact of genotype on the 2019 ARVC risk calculator (2022) (0)
[Rationale and significance of the Italian Network for Cardiac Amyloidosis]. (2023) (0)
[Cardiological counseling and perioperative management of heart disease patients. Protocol of the University of Trieste - Year 2019]. (2019) (0)
The EINSTEIN I-RAP study Evaluation of INferior vena cava by Semi-automaTEd tracking as non INvasive estimation ofIntermediate - Right Atrial Pressure (a pilot study) (2017) (0)
Abstract 16938: Late Gadolinium Enhancement on Cardiac Magnetic Resonance as Predictor of Overall Mortality in Patients With Non-Ischemic Cardiomyopathy (2018) (0)
207 RE-DEFINING ARRHYTHMOGENIC CARDIOMYOPATHY: CHARACTERIZATION AND LONG-TERM PROGNOSTIC IMPLICATIONS (2022) (0)
Endomyocardial Biopsy -- Dilated Cardiomyopathy: From Genetics to Clinical Management (2019) (0)
[Treatment of heart failure: an update]. (2002) (0)
333 Phrenic nerve neuropathy discovered with cardiopulmonary exercise test in long-COVID-19 syndrome (2021) (0)
324Prognostic role of late gadolinium enhancement in patients with low or intermediate HCM SCD risk score: a multicenter study (2019) (0)
The impact glycosylated hemoglobin level on admission plasma beta amyloid in patients with acute myocardial infarction (2023) (0)
Endomyocardial Biopsy (2019) (0)
Persistent High Burden of Heart Failure Across the Ejection Fraction Spectrum in a Nationwide Setting (2022) (0)
Prevalence, correlates and prognostic relevance of mid-wall late gadolinium enhancement in patients with ischaemic cardiomyopathy (2020) (0)
[Position paper of the Italian Society of Cardiology: The renin-angiotensin-aldosterone system (RAAS) blockade in heart failure patients - Part I: From RAAS identification to clinical trials]. (2022) (0)
[Comparing guidelines for heart failure: AHA 2022 versus ESC 2021]. (2022) (0)
Prognostic role of NSVT in patients with DC and different degree of LV dysfunction on tailored medical treatment (2006) (0)
Multi-ancestry GWAS of the electrocardiographic PR interval identifies 202 loci underlying cardiac conduction (2020) (0)
Long-Term Follow-Up of a Nonprogressive Left Main Coronary Artery Fistula to Right Atrium (2022) (0)
[Uncertainties in cardiovascular risk factors: sodium-glucose cotransporter 2 inhibitors for all diabetic patients with high cardiovascular risk and in all patients with renal insufficiency, regardless of albuminuria? Glucagon-like peptide-1 receptor agonists as a weapon against obesity?] (2023) (0)
155 Predictive role for total and sudden death of non sustained ventricular tachycardia in dilated cardiomyopathy (2003) (0)
Quantitative angiography and optical coherence tomography for the functional assessment of mild-to-moderate coronary stenoses: comparison with fractional flow reserve (2013) (0)
[Vasodilators: which, how, when]. (1988) (0)
1004 AN UNUSUAL, UNAVOIDABLE BUT SUCCESSFUL MANAGEMENT OF TYPE A AORTIC DISSECTION. A CASE REPORT (2022) (0)
716 Prognostic role of circulatory power in patients with idiopathic dilated cardiomiopathy (2007) (0)
Underwriting Inherited or Acquired Cardiomyopathies (2013) (0)
Reazioni avverse cardiovascolari (2009) (0)
Revisiting a Prognosticating Algorithm from Cardiopulmonary Exercise Testing in Chronic Heart Failure (from the MECKI Score Population). (2022) (0)
Dilated Cardiomyopathy: Does Etiological Heterogeneity Portend Clinical Heterogeneity? (1998) (0)
Guidelines for the Management of Patients with Heart Failure (2005) (0)
506 A multidisciplinary study on the causes of death in patients hospitalized for hearth failure (2003) (0)
The Role of Clinical Observation: Red Flag 7 — Syndromic and Multi-system Cardiomyopathies (2013) (0)
[Hospital-field comprehensive care models for the management of the patient with failure]. (1999) (0)
564 Patients affected by heart failure with peak oxygen consumption between 10‐18 ml/kg/min: cardiopulmonary test offers additional parameters for a better prognostic stratification? (2007) (0)
149 Perimyocarditis: clinical‐echocardiographic features and medium‐long‐term follow‐up (2008) (0)
106 A CASE OF COMPLETE ATRIOVENTRICULAR BLOCK AND ALTERNATING BUNDLE BRANCH BLOCK DUE TO FULMINANT MYOCARDITIS (2022) (0)
565 Prognostic role of cardiopulmonary exercise indexes in patients with heart failure receiving beta‐blockers (2007) (0)
1041 ELECTROCARDIOGRAPHIC HETEROGENEITY OF PATIENTS WITH VARIANT TRANSTHYRETIN AMYLOID CARDIOMYOPATHY: GENOTYPE PHENOTYPE CORRELATIONS (2022) (0)
1072 A RARE CASE OF CONSTRICTIVE PERICARDITIS AFTER A STAB WOUND TO THE CHEST (2022) (0)
1040 Unexpected prevalence of subtle systolic and diastolic dysfunction in genotype-positive phenotype-negative relatives of dilated cardiomyopathy patients (2020) (0)
[Palliative inotrope therapy in advanced heart failure: organization and management]. (2020) (0)
Clinical outcome of a large cohort of patients with low-gradient aortic stenosis despite preserved left ventricular ejection fraction (2013) (0)
Corrigendum to ‘Supraventricular Tachycardia Causing Left Ventricular Dysfunction’[The American Journal of Cardiology 159 (2021) 72-78] (2021) (0)
Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications (2022) (0)
Thoracic Pain: Clinical Features (2019) (0)
679 Which patients with idiopathic dilated cardiomyopathy still have IDC indications according to scdheft criteria after optimization of medical treatment (2008) (0)
Performance of risk stratification scores and role of comorbidities in older vs younger patients with pulmonary arterial hypertension. (2023) (0)
Definition, Classification, Epidemiology, and Clinical Relevance of Cardiomyopathies (2014) (0)
Unmasking the prevalence of cardiac amyloidosis in the real world: first insights from the phase 2 of the AC-TIVE study, an italian nationwide survey (2022) (0)
141 Long term outcome of dilated cardiomyopathy: a large cohort of patients from the Heart Muscle Disease Registry of Trieste (2008) (0)
86 STEMI and multivessel disease: medical therapy amplifies the benefit of complete myocardial revascularization (2021) (0)
Clinical impact of myocardial fibrosis in severe aortic stenosis (2021) (0)
135 ASSOCIATION OF TRICUSPID REGURGITATION WITH OUTCOME IN ACUTE HEART FAILURE (2022) (0)
Correction: Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications (2022) (0)
OP-EUPA210147 1603..1611 (2021) (0)
284 The incremental prognostic significance of restrictive filling pattern in hypertrophic cardiomyopathy: a Doppler echocardiographic study (2006) (0)
361 Evaluation of systolic and diastolic dysfunction in hypertrophic cardiomyopathy with echocardiography (2004) (0)
Self-reported physical activity and major adverse events in patients with atrial ﬁbrillation: a report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry , on behalf of the EORP-AF General Pilot Registry Investigators † (2016) (0)
105 A CASE OF RARE ATYPICAL ATRIAL STRUCTURE (2022) (0)
Relation of functional improvement due to metoprolol to subsequent outcome in idiopathic dilated cardiomyopathy (2000) (0)
DELETERIOUS IMPACT OF MILD ANEMIA ON SURVIVAL OF YOUNG PATIENTS WITH IDIOPATHIC DILATED CARDIOMYOPATHY. DATA FROM TRIESTE CARDIOMYOPATHIES REGISTRY (2010) (0)
Cardiomyopathy, myocarditis and pericarditis (2010) (0)
Sudden Cardiac Death in Athletes: Facts and Fallacies (2023) (0)
12.8 ICD for primary and secondary prevention of sudden death in patients with dilated cardiomyopathy (2003) (0)
172 CLINICAL AND PROGNOSTIC IMPLICATIONS OF RV UPTAKE WITH RADIONUCLIDE SCINTIGRAPHY IN TRANSTHYRETIN CARDIAC AMYLOIDOSIS (2022) (0)
COVID-19: how things change in a short while (2020) (0)
DEFINITIONS, EPIDEMIOLOGY AND PREDISPOSING FACTORS (2016) (0)
509 RECURRENCE OF ACUTE MYOCARDIAL INFARCTION AFTER MINOCA: INSIGHTS FROM A MULTICENTRE NATIONAL REGISTRY (2022) (0)
Association between Native Myocardial T1 Mapping and Cardiac Function and Macroscopic Fibrosis in Thalassemia Major (2020) (0)
Person-centered integrated approach in an advanced heart failure clinic (2014) (0)
Genome-wide association meta-analysis of 30,000 samples identifies seven novel for quantitative traits. (2018) (0)
[Italian Society of Cardiology-Italian Society of Nephrology Consensus document: The cardio-renal interaction in the prevention and treatment of cardiovascular diseases - Part I: From cardiovascular risk factors to the mechanisms of cardio-renal syndrome]. (2022) (0)
Current Management and Treatment -- Dilated Cardiomyopathy: From Genetics to Clinical Management (2019) (0)
P5285Pressure-volume relationship by cardiovascular magnetic resonance: feasibility and clinical implications (2019) (0)
[New knowledge on the subject of therapy in cardiac decompensation in the light of large trials]. (1994) (0)
[Triple/quadruple therapy in heart failure: integrating scientific evidence with clinical reasoning]. (2007) (0)
1177 The additive prognostic value of end-systolic pressure-volume relation by CMR in patients with with known or suspected coronary artery disease (2020) (0)
The Arrhythmic Phenotype in Cardiomyopathy. (2021) (0)
941 SARCOIDOSIS: THE IMPORTANCE OF MULTIMODALITY IMAGING (2022) (0)
Optimisation of ICD therapy: indications and new technologies (2011) (0)
138 OUTCOME AND MORPHO-FUNCTIONAL CHANGES ON CARDIAC MAGNETIC RESONANCE IN PATIENT WITH ACUTE MYOCARDITIS FOLLOWING MRNA COVID 19 VACCINATION (2022) (0)
Characterization of Cardiac Function by Echocardiographic Global Longitudinal Strain in a Cohort of Children with Neurofibromatosis Type 1 Treated with Selumetinib (2022) (0)
490 Changing mortality in dilated cardiomyopathy in the last 30 years: the experience oh the heart muscle disease registry of trieste (2008) (0)
127 APPLICABILITY AND PERFORMANCE OF HEART FAILURE PROGNOSTIC SCORES IN DILATED CARDIOMYOPATHY: THE EXPERIENCE OF AN ITALIAN REFERRAL CENTER FOR CARDIOMYOPATHIES (2022) (0)
379 Contemporary use of guideline directed medical therapy in dilated cardiomyopathy: therapeutic optimization and prognostic benefits (2021) (0)
Participatory meeting: a new educational program based on bottom-up learning approach. (2023) (0)
915 PHENOTYPIC EXPRESSION AND OUTCOMES OF CARDIOMYOPATHY CAUSED BY TITIN TRUNCATING VARIANTS: TRANSLATIONAL INSIGHTS (2022) (0)
Cohort profile The ESC-EORP Chronic Ischemic Cardiovascular Disease Long-Term (CICD LT) registry. (2019) (0)
Proportion of patients with idiopathic dilated cardiomyopathy and SCDHeFT characteristics on diagnosis and during follow-up (2007) (0)
Transmural myocardial infarction. Focus on current strategies of myocardial reperfusion (2003) (0)
Molecular epidemiology of lamin A/C gene mutations in dilated cardiomyopathy (2001) (0)
TACHYCARDIA IN PREDICTING THE RISK OF DEATH IN IDIOPATHIC DILATED CARDIOMYOPATHY: RESULTS FROM A LARGE REGISTRY OF PTS WITH A LONG FOLLOW-UP (2015) (0)
[Treatment of acute high-risk pulmonary embolism]. (2011) (0)
Prognostic role of hemodynamic evaluation at rest and at maximum workload in patients with idiopathic dilated cardiomyopathy. (2011) (0)
Pilot‐study of home‐based intervention program for patients with refractory heart failure (2000) (0)
Unresolved Issues and Future Perspectives (2019) (0)
Cardiomyopathies in children: classification, diagnosis and treatment. (2020) (0)
[ANMCO/FADOI/SIAARTI/SIC/SIMG/SIMI/SIMEU consensus document: The clinical care pathway of acute heart failure patients from symptom onset to discharge from the emergency department]. (2019) (0)
Acute Management of Patients with Arrhythmias and Non-cardiac Diseases: Metabolite Disorders and Ion Disturbances (2016) (0)
[Italian Society of Cardiology-Italian Society of Nephrology Consensus document: The cardio-renal interaction in the prevention and treatment of cardiovascular diseases - Part II: From preventive strategies to treatment of patients with cardio-renal damage]. (2022) (0)
382 Clinical manifestation and prognosis of different cardiomyopathies on the base of genetic background (GEN-PHEN) (2021) (0)
89 Clinical course in patients with active myocarditis according to the type of clinical presentation (2007) (0)
733 Prognostic role of haemodynamic evaluation at rest and during exercise in patients with idiopathic dilated cardiomyopathy (2007) (0)
841 Impact of anemia and renal dysfunction on cognitive function in elderly patients with heart failure (2005) (0)
Abstract 15184: In vivo Functional cDNA Selection Identifies Ghrelin as a Novel, Powerful Cardioprotective Molecule (2010) (0)
Remote multiparametric monitoring and management of heart failure patients through cardiac implantable electronic devices. (2023) (0)
Signalling through the VEGF-1 receptor preserves cardiomyocyte viability and improves cardiac function after myocardial infarction (2008) (0)
PREDICTORS OF MAJOR ADVERSE CARDIAC EVENTS IN LONG-TERM FOLLOW-UP AFTER CARDIAC REHABILITATION (2017) (0)
871 AN ADVANCED BREATHING DISORDER IN HEART FAILURE: IS THERE AN OVERLAP THROUGH EXERCISE OSCILLATORY VENTILATION AND CHEYNE-STOKES RESPIRATION? A CASE REPORT (2022) (0)
641 A CONTROVERSIAL CASE OF FABRY DISEASE: ADDING ANOTHER PIECE TO THE INTERPRETATION PUZZLE OF C.376A>G MISSENSE MUTATION, A PATHOGENIC VARIANT (2022) (0)
The K219T-Lamin mutation induces conduction defects through epigenetic inhibition of SCN5A in human cardiac laminopathy (2019) (0)
The Role of Clinical Observation: Red Flag 4 — Cardiomyopathies and Sensorineural Hearing Loss (2013) (0)
Competing risks between mortality and heart failure hospital re-admissions: a community-based investigation from the Trieste area (2016) (0)
New perspectives in diagnosis and risk stratification of non-ischaemic dilated cardiomyopathy (2023) (0)
754 Frailty is strongly associated to cardio‐renal‐anemia syndrome in elderly community‐living heart failure patients (2006) (0)
[Out-of-hospital cardiac arrest: University of Trieste students' skills on resuscitative maneuvers and automated external defibrillator]. (2023) (0)
Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) (2015) (0)
259 PERICARDITIS AND PERICARDIAL EFFUSION IN CHRONIC GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (2022) (0)
Paracrine effect of regulatory T cells promotes cardiomyocyte proliferation during pregnancy and after myocardial infarction (2018) (0)
P1629Crispr/Cas9 to elucidate cardiac specific effects of Gdf11 (2019) (0)
Regenerative Medicine and Biomarkers for Dilated Cardiomyopathy -- Dilated Cardiomyopathy: From Genetics to Clinical Management (2019) (0)
480 ICD AFTER STEMI: WHEN AND HOW FREQUENTLY IS IMPLANTED AND WHICH IS THE RATE OF APPROPRIATE INTERVENTIONS (2022) (0)
738 A RARE CASE OF UNICUSPID AORTIC VALVE WITH SEVERE STENOSIS AND REGURGITATION: CLINICAL PRESENTATION AND MANAGEMENT (2022) (0)
Linkage of autosomal dominant familial dilated cardiomyopathy to chromosome 9 (1996) (0)
Abstract 13018: Clinical Impact of Desmosomal and Titin Gene Mutations on the Natural History of Arrhythmogenic Right Ventricular Cardiomyopathy (2013) (0)
PREVALENCE AND PROGNOSTIC VALUE OF DIABETES MELLITUS (DM) IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI) FOR ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (STEMI) (2008) (0)
The late-onset dilated cardiomyopathy (2020) (0)
Emergency Surgery and Cardiac Devices (2016) (0)
[Heart failure: causes and therapy of unstableness]. (1995) (0)
[Tricuspid regurgitation and indications for treatment]. (2019) (0)
Whole-exome sequencing: Clinical characterization of pediatric and adult Italian patients affected by different forms of hereditary cardiovascular diseases. (2023) (0)
338Myocardial deformation imaging for the assessment of left ventricular function in arrhythmogenic right ventricular cardiomyopathy: a feature tracking cardiac magnetic resonance study (2019) (0)
Cardiomyopathies in children: classification, diagnosis and treatment. (2020) (0)
Effects of COVID-19 on cardiovascular fellowship in Italy (2020) (0)
Contributors (2019) (0)
Corrigendum to "Long-term prognostic role of diabetes mellitus and glycemic control in heart failure patients with reduced ejection fraction: Insights from the MECKI Score database" [Int J Cardiol. 2020 Oct 15; 317: 103-110. PMID: 32360652]. (2021) (0)
466 OUT-OF-HOSPITAL CARDIAC ARREST: UNIVERSITY OF TRIESTE STUDENTS’ KNOWLEDGE OF CARDIOPULMONARY RESUSCITATION AND DEFIBRILLATOR USE (2022) (0)
Is It Possible to Predict the Synergistic Benefit of Combinated Effective Drugs in Congestive Heart Failure (2004) (0)
[The Regional Registry of Sudden Cardiac Death of Friuli Venezia Giulia. Protocols, best practices and results of a multidisciplinary project]. (2022) (0)
Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: A Contemporary Perspective (2023) (0)
Clinical and echocardiographic progression of hypertrophic cardiomyopathy (2000) (0)
89 Rate and prognostic significance of atrial fibrillation in patients with idiopathic dilated cardiomyopathy (2005) (0)
[Reply to "Defining priorities, the case of of COVID-19 vaccine"]. (2021) (0)
Prognosis and mechanism of death in treated heart failure: data from the placebo arm of Val-HeFT (2003) (0)
Antithrombotic therapy in heart failure and sinus rhythm: the ongoing search for a better match of patients to therapy (2020) (0)
Single coronary artery anomaly and chest pain. (2017) (0)
A Large Ostium Secundum Atrial Septal Defect in an 88‐Year‐Old Asymptomatic Woman (2016) (0)
310 Ruptured sinus of Valsalva aneurysm as a rare cause of sisto-diastolic murmur: role of multimodality imaging in diagnosis and surgical planning (2021) (0)
INTEGRATING MYOCARDIAL STRAIN AND EXERCISE PERFORMANCE INTO PROGNOSTICATION OF HYPERTROPHIC CARDIOMYOPATHY (2017) (0)
Dilated Cardiomyopathy at the Crossroad: Multidisciplinary Approach -- Dilated Cardiomyopathy: From Genetics to Clinical Management (2019) (0)
Chronic thromboembolic pulmonary hypertension risk score evaluation and validation (CTEPH Solution): proposal of a study protocol aimed to realize a validated risk score for early diagnosis. (2021) (0)
2422Outcome of histologically-proven fulminant versus acute non-fulminant myocarditis with left ventricular systolic dysfunction. Evidence from the International Registry on Acute Myocarditis (2019) (0)
PHYSICAL ACTIVITY AND MAJOR ADVERSE EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION: A REPORT FROM THE EUROBSERVATIONAL RESEARCH PROGRAMME PILOT SURVEY ON ATRIAL FIBRILLATION (EORP-AF) GENERAL REGISTRY (2016) (0)
31 Predictive role of non sustained ventricular tachycardia for all‐cause and unexpected sudden cardiac death in patients with idiopatic dilated cardiomyopathy (2004) (0)
Non-transplant surgery for heart failure and severe left ventricular dysfunction. Opportunities and limitations. (2003) (0)
AMBULATORY CARDIAC REHABILITATION IN HIGH RISK PATIENTS WITH DIABETES: DATA FROM A REGISTRY OF ALL COMERS PATIENTS AFTER CORONARY REVASCULARIZATION (2013) (0)
152 PERFORMANCE OF RISK STRATIFICATION SCORES AND ROLE OF COMORBIDITIES IN OLDER VS YOUNGER PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (2022) (0)
IncidenCe and predictOrs of heaRt fAiLure after acute coronarY Syndrome: The CORALYS registry. (2022) (0)
[Author reply]. (2021) (0)
146 Prognostic significance of unexplained left ventricular hypertrophy in patients undergoing carpal tunnel surgery (2021) (0)
580 INCIDENCE AND FACTORS ASSOCIATED WITH DE NOVO ATRIAL FIBRILLATION IN PATIENTS WITH WILD-TYPE TRANSTHYRETIN CARDIAC AMYLOIDOSIS - A MULTICENTER STUDY (2022) (0)
Inflammasome formation in the lungs of patients with fatal COVID-19 (2020) (0)
Additive effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction in spite of chronic metoprolol (1999) (0)
The fate of a composite arterial graft in a 58-year-old man having strong comorbidities and atherosclerotic burden (2017) (0)
Chapter 3: Pathophysiology (2019) (0)
Echocardiographic findings in myocarditis. Initial and follow-up observations (2006) (0)
Conventional Cardiological Therapies (2020) (0)
802 DIAGNOSTIC YIELD AND PREDICTIVE VALUE ON LEFT VENTRICULAR REVERSE REMODELING OF GENETIC TESTING IN DILATED CARDIOMYOPATHY (2022) (0)
Abstract 15012: Role of Titin Gene Variants in Human Dilated Cardiomyopathy (2013) (0)
114. Efficient Arterial Formation at the Sites of Adult Neo-Angiogenesis Requires the Recruitment of Bone Marrow Cells through the Neuropilin-1 (NP-1) Receptor (2005) (0)
Paradoxical Pulmonary Embolism in a Patient with Bilateral Renal Infarction: The Role of Contrast-enhanced Ultrasound Imaging (2022) (0)
302 Implantable defibrillator for primary and secondary prevention of sudden death in dilated cardiomyopathy (2003) (0)
972 PULMONARY HYPERTENSION AND EMBRYOLOGICAL REMNANT: WHAT DO THEY HAVE TO DO WITH EACH OTHER? A CASE REPORT (2022) (0)
334 AMYLOID-BETA 1-40 AND DAPT IN ACUTE MYOCARDIAL INFARCTION (2022) (0)
Use of Social Media by Cardiovascular Health Care Professionals: Is Patient Privacy Respected? (2021) (0)
The Role of Clinical Observation: Red Flag 2 — Cardiomyopathies and Arrhythmias (2013) (0)
Endomyocardial fibrosis of the right ventricle: A case report of successful surgery (2019) (0)
Linkage ofFamilial Dilated Cardiomyopathy toChromosome9 (1995) (0)
Cardiovascular Damage in COVID-19: What We Know Two Years Later (2022) (0)
The Role of Clinical Observation: Red Flag 6 — Left Ventricular Non-Compaction (2013) (0)
Benefits of beta-blockers in heart failure: a class specific effect? (2001) (0)
P1282 Follow-up evaluation of right chambers mechanics is associated with prognosis in group 1 pulmonary arterial hypertension (2020) (0)
125 Sex differences in myocarditis natural history (2021) (0)
Prevalence, Correlates, and Prognostic Relevance of Mid-Wall Late Gadolinium Enhancement in Patients With Ischemic Cardiomyopathy. (2020) (0)
Coronavirus disease 2019 vaccination-related pericarditis: a single tertiary-center experience (2022) (0)
Comprar Genetic Cardiomyopathies. A Clinical Approach | G. Sinagra | 9788847027565 | Springer (2013) (0)
[Refractory heart failure. Positive inotropes and beta blockers: alternative or complementary treatments?]. (2002) (0)
Cardiac magnetic resonance abnormalities in patients with acute myocarditis proven by septal endomyocardial biopsy (2022) (0)
The importance of re-evaluating the risk score in heart failure patients: An analysis from the Metabolic Exercise Cardiac Kidney Indexes (MECKI) score database. (2023) (0)
Long-term survival effect of metoprolol in dilated cardiomiopathy (1998) (0)
P892 Accuracy of right atrial pressure estimation using a multi-parameter approach derived from Inferior vena cava semi-automated edge-tracking echocardiography (2020) (0)
[Transcatheter devices for chronic heart failure: state of the art]. (2022) (0)
Pathophysiology -- Dilated Cardiomyopathy: From Genetics to Clinical Management (2019) (0)
[Position paper of the Italian Society of Cardiology: The renin-angiotensin-aldosterone system blockade in heart failure patients - Part II: Mechanistic effects of sacubitril/valsartan, placement in current guidelines and use in clinical practice]. (2022) (0)
Might midodrine be useful in patients with decompensated and worsening chronic heart failure? Author's reply. (2022) (0)
253 EXCERCISE-INDUCED PULMONARY HYPERTENSION AND CORONARY ARTERY ANOMALY: AN UNUSUAL ASSOCIATION (2022) (0)
1111 Atrial thrombi or cardiac tumors? The challenge of multimodality imaging of intracardiac masses (2020) (0)
280 Role of the electrocardiogram in differentiating genotype positive dilated cardiomyopathy from cardiac remodelling in athletes (2021) (0)
The Role of Clinical Observation: Red Flag 1 — Cardiomyopathies and Skeletal Muscle Involvement (2013) (0)
CLINICAL MANIFESTATION AND PROGNOSIS OF DIFFERENT CARDIOMYOPATHIES ON THE BASE OF GENETIC BACKGROUND (GEN-PHEN) (2022) (0)
Naive Bayesian-based Nomogram for Identification of Early Asymptomatic Dilated Cardiomyopathy (2022) (0)
Contrast induced nephropathy: a new predictive model based on pre procedural glycemia and glomerular filtration rate (2013) (0)
Sudden Death in Heart Failure: Risk Stratification and Treatment Strategies (2007) (0)
Abstract 19853: Role of Velocity Vector Imaging Derived Strain Parameters in Arrhythmogenic Right Ventricular Cardiomyopathy (2014) (0)
338 PREVALENCE AND PERSISTENCE OF HYPOVITAMINOSIS D AMONG ITALIAN PATIENTS WITH MYOCARDIAL INFARCTION (2022) (0)
[Selection criteria to cardiac surgery, transcatheter valvular interventions, electrophysiology and pacing procedures in patients with advanced heart failure]. (2020) (0)
Evolving mortality and clinical scenarios in HCM: Where are we? (2023) (0)
Etiological Definition and Diagnostic Work-Up -- Dilated Cardiomyopathy: From Genetics to Clinical Management (2019) (0)
Abstract 17211: Titin Mutations Cause Arrhythmogenic Right Ventricular Cardiomyopathy (2010) (0)
Lo scompenso cardiaco nell’anziano (2007) (0)
How cardiologists can manage excess body weight and related cardiovascular risk. An expert opinion. (2023) (0)
Prognostic Stratification and Importance of Follow-Up (2019) (0)
P711Dilated cardiomyopathy with Mid-range ejection fraction at diagnosis: characterization and natural history (2017) (0)
[Diagnostic work-up and clinical management of cardiomyopathies: the operative protocol from the Cardiothoracovascular Department of Trieste, Italy]. (2020) (0)
525 A novel role for bone marrow stem cells in arteriogenesis in vivo (2006) (0)
Lamin A/C gene mutations in families with dilated cardiomyopathy, conduction system defects, and skeletal muscle disease (2001) (0)
131 A MORE UNIQUE THAN RARE MYOPERICARDITIS - A CASE REPORT (2022) (0)
632 Diagnostic and prognostic performance of HFA-PEFF and H2FpEF scores in patients with cardiac amyloidosis (2021) (0)
THE CLOSE RELATIONSHIP BETWEEN DRUG INTOLERANCE AND MAJOR CARDIAC AND CEREBROVASCULAR EVENTS AFTER AN ACUTE CORONARY SYNDROME OR CORONARY REVASCULARIZATION (2017) (0)
Arrhythmic risk stratification in non-ischaemic dilated cardiomyopathy (2023) (0)
258 CORONAVIRUS DISEASE 19 VACCINATION-RELATED PERICARDITIS: A SINGLE TERTIARY CENTER EXPERIENCE (2022) (0)
Abstract 15666: The Mecki Score: A More Accurate Prognostic Tool in Patients With Heart Failure. A Multicenter Comparison With Shfm and Hfss in a Large Cohort of Patients (2016) (0)
Diagnosis and Management of Cardiomyopathies – A Focus on Genetics, Cardiac Magnetic Resonance and Clinical Features. (2011) (0)
Abstract 194: Characterization of Arrhythmogenic Dilated Cardiomyopathy Caused by Novel Filamin C Splice Variant in a Zebrafish Model (2015) (0)
P205 PROGNOSTIC VALUE OF AMYLOID–Β (1–40) IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION (2022) (0)
Controversial Issues on β-Blocker Treatment: Has Metoprolol an Additive Effect to Conventional Medical Treatment in Heart Failure Due to Dilated Cardiomyopathy? (1998) (0)
Infolding of self-expandable transcatheter valve: A complication that needs prompt diagnosis during TAVR procedure. (2022) (0)
The Trieste Observatory of cardiovascular disease: an experience of administrative and clinical data integration at a regional level (2017) (0)
Prognostic significance and the evolution of renal insufficiency in COMET trial (2004) (0)
[Italian Society of Cardiology (SIC) Position paper: Technical, instrumental and standards of interpretation for electrocardiography, ambulatory electrocardiographic and blood pressure monitoring in telemedicine]. (2021) (0)
Has the prognosis of idiopathic dilated cardiomyopathy improved in the community? The heart muscle disease registry of Trieste (2000) (0)
DILATED CARDIOMYOPATHY WITH MIDRANGE EJECTION FRACTION AT DIAGNOSIS: CHARACTERIZATION AND NATURAL HISTORY (2018) (0)
Hypertrophic Cardiomyopathy: Clinical Assessment and Differential Diagnosis (2014) (0)
Genetic architecture of spatial electrical biomarkers for cardiac arrhythmia and relationship with cardiovascular disease (2023) (0)
292 Factors associated with increased risk of sudden death in patients with idiopathic dilated cardiomyopathy (2006) (0)
Correction to: The genetic architecture of Plakophilin 2 cardiomyopathy (2021) (0)
697 Atrial fibrillation and hospitalisation rate in patients with idiopathic dilated cardiomyopathy (2007) (0)
Immunogenetic studies in familial dilated cardiomyopathy Lack of evidence for linkage to HLA locus (1993) (0)
Racial differences in val 122 Ile associated transthyretin cardiac amyloidosis (2021) (0)
The curious case of a massive right heart thrombosis: a case report (2021) (0)
[The ECG as a "red flag" and potential prognostic predictor (2)]. (2023) (0)
Gender differences in heart failure (2017) (0)
191 Prognostic value of amyloid beta (1–40) in patients with acute myocardial infarction (2021) (0)
85 Diuretics trajectories in dilated cardiomyopathy (2021) (0)
Current Management and Treatment (2019) (0)
362 Trends in the use/non-use of guideline-directed medical therapy in non-ischaemic dilated cardiomyopathy with improved ejection fraction (2021) (0)
CARDIAC MAGNETIC RESONANCE PHENOTYPE AND GENOTYPE IN LEFT-SIDED CARDIOMYOPATHIES: CHARACTERIZATION AND CLINICAL OUTCOMES (2023) (0)
Increased myocardial extracellular volume is associated with myocardial iron overload and heart failure in thalassemia major (2022) (0)
Use of and Association between Heart Failure Pharmacological Treatments and Outcomes in Obese vs. non-Obese Patients with Heart Failure with Reduced Ejection Fraction: Data from the Swedish Heart Failure Registry. (2023) (0)
411 AN UNEXPECTED (AND UNDESIRED) ECHOCARDIOGRAPHIC FINDING IN A PATIENT WITH RIGHT-SIDED CHEST PAIN (2022) (0)
Scompenso cardiaco congestizio (2010) (0)
PROGNOSTIC IMPACT OF TRANS-CATHETER ATRIAL FIBRILLATION ABLATION ON HYPERTROPHIC CARDIOMYOPATHY OUTCOME: A MULTICENTER RETROSPECTIVE LONG-TERM FOLLOW UP STUDY (2021) (0)
Abstract 15759: Arrhythmic Risk Stratification in Patients With Idiopathic Dilated Cardiomyopathy and No Conventional Indications for Implantable Cardiac Defibrillator (2014) (0)
251 Increased cytokine expression in adipose tissue and blood cells of heart failure patients with atrial fibrillation (2006) (0)
Novel Classification of Ischemic Heart Disease Using Artificial Neural Network (2020) (0)
Ambulatory cardiac rehabilitation in elderly patients after coronary revascularization: one-year follow up and outcome (2013) (0)
ICD-detected respiratory disturbance index: accuracy for sleep apnea detection and prognostic value (2020) (0)
228 PD-1-TARGETED T-CELL CHECKPOINT INHIBITORS-RELATED MYOCARDITIS COMPLICATED BY COMPLETE ATRIOVENTRICULAR BLOCK: A CASE SERIES OF SUCCESSFUL MANAGEMENT (2022) (0)
Prognostic relevance of pericardial effusion in STEMI patients treated by primary percutaneous coronary intervention: a 10-year single-centre experience. (2019) (0)
Clinical Presentation, Spectrum of Disease, and Natural History (2019) (0)
Cardiac Biomarkers in the Emergency Department : the role of sST 2 in acute heart failure and acute coronary syndrome-There is meat on the bone (2019) (0)
Pulmonary Embolism Presenting with Pulmonary Infarction: Update and Practical Review of Literature Data (2022) (0)
Short-and long-term mortality and heart failure hospital re-admissions among patients hospitalised for heart failure: a regional population-based investigation from Italy. European Journal of Heart Failure (2016) (0)
[Beta blocking agents in the treatment of dilated cardiomyopathy: review of the literature and clinical experience with 67 patients]. (1992) (0)
162 HFREF WITH IMPROVED EJECTION FRACTION AFTER CORONARY ARTERY BYPASS GRAFT (CABG) AND REVERSE REMODELING PREDICTOR FACTORS (2022) (0)
Heart Failure, Atrial Fibrillation, and Diabetes Mellitus (2007) (0)
Abstract 2935: Clinical-Instrumental Characteristics and Prognosis in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy: 30 Years of Experience in a Referral Center (2008) (0)
262 An attractive endovascular strategy for combined—aneurysmal and stenotic—coronary artery disease (2021) (0)
755 Rat engineered heart tissue is a novel in vitro model to evaluate cardiomyocyte proliferation and fibroblast activation after injury (2021) (0)
158 Racialdifferencesinval122Ileassociatedtransthyretincardiac amyloidosis (2021) (0)
471 IMPACT OF COMPLETE REVASCULARIZATION ON DEVELOPMENT OF HEART FAILURE IN PATIENTS WITH ACUTE CORONARY SYNDROME AND MULTIVESSEL DISEASE (2022) (0)
Pragmatic electrocardiogram tracings in non-ischaemic dilated cardiomyopathy: diagnostic and prognostic role (2023) (0)
734 APHASIC AORTITIS - A CASE REPORT (2022) (0)
Mechanical loading regulates cardiomyocyte proliferation (2022) (0)
Overweight and obesity in female and male patients with atrial fibrillation: insights from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Pilot Registry (2016) (0)
19 Alpha‐myosin heavy chain mutations associated with dilated and hypertrophic cardiomyopathy (2004) (0)
[Ten questions about eosinophilic myocarditis]. (2022) (0)
Vitamin D and Cardiovascular Diseases (2019) (0)
Native T1 Values and Cardiac Involvement in Patients with Thalassemia Major (2020) (0)
Unexpected cause of pericarditis: Chest teratoma. (2021) (0)
Preserved skeletal muscle mitochondrial function, redox state and mass in obese mice with chronic heart failure (2018) (0)
Coronary angiography after rosc: is ECG without stemi still an open question? (2019) (0)
Tissue doppler imaging and cardiopulmonary testing: insight into idiopathic dilated cardiomyopathy (2013) (0)
440 Is pacemaker implantation indicated to treat heart failure patients with beta-blockers? (2004) (0)
[Takotsubo or peripartum cardiomyopathy? A challenging clinical dilemma]. (2014) (0)
Erratum to "Routine use of bilateral internal thoracic artery grafting in women does not increase in-hospital mortality and could improve long-term survival" [Int. J. Cardiol. 266 (2018) 43-49]. (2018) (0)
[Ten questions for the cardiologist about cardiac scintigraphy with bone tracers, amyloidosis and the heart]. (2022) (0)
DOUBLE TROUBLE: DUCTAL ORIGIN OF RIGHT PULMONARY ARTERY WITH CONTRALATERAL EMBOLISM (2022) (0)
Cardiovascular death risk in mid-range ejection fraction heart failure: insights from cardiopulmonary exercise test (2021) (0)
The double anaerobic threshold in heart failure: MECKI score database overview (2022) (0)
Effect of carvedilol on left ventricular geometry in patients with dilated cardiomyopathy poor responders to chronic metoprolol (1999) (0)
Abstract 17749: Immune Modulation by Regulatory T Cells Preserves Cardiac Function and Promotes Cardiomyocyte Proliferation After Myocardial Infarction (2013) (0)
Balloon valvuloplasty after Transcatheter Aortic Valve Implantation (TAVI): always safe? (2014) (0)
Comparative effects of carvedilol and metoprolol on ventricular remodeling process in idiopathic dilated cardiomyopathy. A randomized cross-over study (2000) (0)
[The epidemiology of heart failure: a growing public health problem]. (1995) (0)
Calcific degeneration and rupture of the aortic valve and ascending aorta: from cardiac auscultation to multimodality imaging (2015) (0)
116 Danon disease explains the phenotype in a family originally reported as XLCM (2005) (0)
[Sudden cardiac death in patients with left ventricular dysfunction from ischemic heart disease: role of the implantable defibrillator. Evidence, guidelines and good clinical judgment]. (2012) (0)
Right ventricular Dysplasia: a new form of cardiomyopathy? (1994) (0)
Gene therapy with AAV vectors to promote neovascularization and mobilization of bone-marrow progenitor cells (2004) (0)
T02-P-003 Modifications of lipid and inflammatory parameters during acute myocardial infarction (2005) (0)
Evolving trends in epidemiology and natural history of cardiac amyloidosis: 30-year experience from a tertiary referral center for cardiomyopathies (2022) (0)
281 Anthracycline-induced cardiomyopathy: characteristics and outcome (2006) (0)
[Safety and tolerability of beta-blockers in severe cardiac decompensation from dilated cardiomyopathy]. (1995) (0)
Myocardial native T1 mapping and correlations with clinical and CMR parameters in patients with systemic sclerosis (2021) (0)
SCN5A MUTATIONS ASSOCIATED WITH DILATED CARDIOMYOPATHY COMMONLY LOCALIZE TO THE VOLTAGE-SENSING MECHANISM (2010) (0)
Dilated Cardiomyopathy: Clinical Assessment and Differential Diagnosis (2014) (0)
Cellular Biomechanic Impairment in Cardiomyocytes Carrying the Progeria Mutation: An Atomic Force Microscopy Investigation (2022) (0)
The Fate of a Composite Arterial Graft in a 58-Year-Old Man with Strong Comorbidities and Atherosclerotic Burden (2016) (0)
Abstract 13095: Phenotype, Genotype and Natural History of Arrhythmogenic Dilated Cardiomyopathy (2013) (0)
8 Which is the best time to perform ICD implantation in patients with idiopathic dilated cardiomyopathy (2007) (0)
Heart failure with supra‐normal left ventricular ejection fraction: distinct polygenic bases of an unrecognized phenotype (2022) (0)
418 Titin mutations and female sex characterize dilated cardiomyopathy in the elderly (2021) (0)
Abstract 12107: Persistent Long-Term Apparent Healing in a Large Cohort of Patients With Idiopathic Dilated Cardiomyopathy: Prevalence and Characterization (2013) (0)
Heart failure and trial generated patients' profile for implant with electrical devices: real-world prevalence, outcomes and public health implications. (2006) (0)
Micro-RNA therapy stimulates endogenous cardiac regeneration after myocardial infarction (2018) (0)
Hidden left ventricular sarcoma manifesting itself with cardiogenic shock (2022) (0)
Abstract 5936: Can Apoptosis Predict Functional Recovery in Acute Myocarditis? (2008) (0)
Abstract session 12: Advances in resynchronization therapy (2007) (0)
CHA2DS2-VASc Score Predicts Adverse Outcome in Patients with Simple Congenital Heart Disease Regardless of Cardiac Rhythm (2020) (0)
Time to reconsider thromboembolic risk and anticoagulation in transthyretin cardiac amyloidosis? (2022) (0)
485 PROGNOSTIC IMPACT OF TREATMENTS EVOLUTION IN STEMI: INSIGHTS FROM A PRIMARY PCI REGISTRY (2022) (0)
Dilated Cardiomyopathy and Steps in the treatment. (2001) (0)
415 Correlation between tissue abnormalities and myocardial deformation indices in arrhythmogenic cardiomyopathy: a pilot study (2021) (0)
[Coronary angioplasty in the aged: short and long term efficacy in patients with unstable angina]. (1992) (0)
118 Undefined left ventricular arrhythmogenic cardiomyopathy: the value of genotyping and histological characterization (2021) (0)
[The ECG as a "red flag" and potential prognostic predictor (1)]. (2023) (0)
Dilated cardiomyopathy: clinical diagnosis and medical management (2018) (0)
PP212-MON ADIPOKINES, GHRELIN AND OBESITY-ASSOCIATED INSULIN RESISTANCE IN NON-DIABETIC PATIENTS WITH ACUTE CORONARY SYNDROME (2012) (0)
189 PREVALENCE, DISEASE CHARACTERISTICS AND OUTCOMES OF HEREDITARY TRANSTHYRETIN AMYLOID CARDIOMYOPATHY AMONG ELDERLY INDIVIDUALS (2022) (0)
149 Familial dilated cardiomyopathy: an international registry (2003) (0)
Abstract 13271: Prognostic Role of Thrombus Aspiration and Glycoprotein IIb/IIIa Inhibitors During Primary Percutaneous Coronary Intervention (2011) (0)
702 Reverse remodelling presenting with apparent healing of Heart Failure patients at mid-long term follow-up after Cardiac Resynchronization Therapy (2008) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Gianfranco Sinagra?

Gianfranco Sinagra is affiliated with the following schools:

Gianfranco Sinagra's Academic­Influence.com Rankings

Gianfranco Sinagra's Degrees

Similar Degrees You Can Earn

Why Is Gianfranco Sinagra Influential?

Gianfranco Sinagra's Published Works

Published Works

What Schools Are Affiliated With Gianfranco Sinagra?

Gianfranco Sinagra's AcademicInfluence.com Rankings